BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Napier KJ, Scheerer M, Misra S. Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol 2014; 6(5): 112-120 [PMID: 24834141 DOI: 10.4251/wjgo.v6.i5.112] [Cited by in CrossRef: 373] [Cited by in F6Publishing: 355] [Article Influence: 46.6] [Reference Citation Analysis]
Number Citing Articles
1 Feng JF, Chen S, Yang X. Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus. Medicine (Baltimore) 2017;96:e5886. [PMID: 28121932 DOI: 10.1097/MD.0000000000005886] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
2 Guan S, Wang C, Chen X, Liu B, Tan B, Liu F, Wang D, Han L, Wang L, Huang X, Wang J, Yao B, Shi J, Chen P, Nesa EU, Song Q, Cheng Y. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma. Tumour Biol 2016;37:4383-91. [PMID: 26499784 DOI: 10.1007/s13277-015-4271-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
3 Okuyama C, Higashi T, Ishizu K, Nakamoto R, Takahashi M, Kusano K, Kagawa S, Yamauchi H. Bone Pseudometastasis on 18F-FDG PET in Japanese Patients With Esophageal Cancer. Clin Nucl Med 2019;44:771-6. [DOI: 10.1097/rlu.0000000000002625] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Hu W, Chen Z, Chen J, Cai D, Chen C, Fang T. LOC441178 Overexpression Inhibits the Proliferation and Migration of Esophageal Carcinoma Cells via Methylation of miR-182. Onco Targets Ther 2020;13:11253-63. [PMID: 33173314 DOI: 10.2147/OTT.S271711] [Reference Citation Analysis]
5 Chagan-Yasutan H, Arlud S, Zhang L, Hattori T, Heriyed B, He N. Mongolian Mind-Body Interactive Psychotherapy enhances the quality of life of patients with esophageal cancer: A pilot study. Complement Ther Clin Pract 2020;38:101082. [PMID: 32056818 DOI: 10.1016/j.ctcp.2019.101082] [Reference Citation Analysis]
6 Wu Y, Wang X, Xu F, Zhang L, Wang T, Fu X, Jin T, Zhang W, Ye L. The regulation of acetylation and stability of HMGA2 via the HBXIP-activated Akt-PCAF pathway in promotion of esophageal squamous cell carcinoma growth. Nucleic Acids Res 2020;48:4858-76. [PMID: 32313942 DOI: 10.1093/nar/gkaa232] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
7 Wang L, Ji XB, Wang LH, Xia ZK, Xie YX, Liu WJ, Qiu JG, Jiang BH, Liu LZ. MiRNA-30e downregulation increases cancer cell proliferation, invasion and tumor growth through targeting RPS6KB1. Aging (Albany NY) 2021;13:24037-49. [PMID: 34727092 DOI: 10.18632/aging.203665] [Reference Citation Analysis]
8 Li M, Jiang HB, Tao ZJ, Wu YN. Extended Free Forearm Flap for Treatment of Temporomandibular Joint Pseudoankylosis. J Craniofac Surg 2015;26:e358-9. [PMID: 26080264 DOI: 10.1097/SCS.0000000000001800] [Reference Citation Analysis]
9 Ke TM, Fong Y, Lin LC, Chien YW, Yang CC, Lin CH, Lin KL, Que J. Evaluating the optimal radiation dose for definitive chemoradiotherapy for esophageal squamous cell carcinoma: A single institution experience. Medicine (Baltimore) 2018;97:e13214. [PMID: 30431596 DOI: 10.1097/MD.0000000000013214] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
10 Hou N, Ma J, Li W, Zhao L, Gao Q, Mai L. T-cell immunoglobulin and mucin domain-containing protein-3 and galectin-9 protein expression: Potential prognostic significance in esophageal squamous cell carcinoma for Chinese patients. Oncol Lett 2017;14:8007-13. [PMID: 29344243 DOI: 10.3892/ol.2017.7188] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
11 Davern M, Donlon NE, Power R, Hayes C, King R, Dunne MR, Reynolds JV. The tumour immune microenvironment in oesophageal cancer. Br J Cancer 2021;125:479-94. [PMID: 33903730 DOI: 10.1038/s41416-021-01331-y] [Reference Citation Analysis]
12 Chen Y, Huang K, Ding X, Tang H, Xu Z. Magnolol inhibits growth and induces apoptosis in esophagus cancer KYSE-150 cell lines via the MAP kinase pathway. J Thorac Dis 2019;11:3030-8. [PMID: 31463132 DOI: 10.21037/jtd.2019.07.46] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
13 Wang P, Yang Z, Ye T, Shao F, Li J, Sun N, He J. lncTUG1/miR-144-3p affect the radiosensitivity of esophageal squamous cell carcinoma by competitively regulating c-MET. J Exp Clin Cancer Res 2020;39:7. [PMID: 31918742 DOI: 10.1186/s13046-019-1519-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
14 Ma J, Xiao Y, Tian B, Chen S, Zhang B, Wu J, Wu Z, Li X, Tang J, Yang D, Zhou Y, Wang H, Su M, Wang W. Long noncoding RNA lnc-ABCA12-3 promotes cell migration, invasion, and proliferation by regulating fibronectin 1 in esophageal squamous cell carcinoma. J Cell Biochem 2020;121:1374-87. [PMID: 31512786 DOI: 10.1002/jcb.29373] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
15 Feng Z, Li X, Qiu M, Luo R, Lin J, Liu B. LncRNA EGFR-AS1 Upregulates ROCK1 by Sponging miR-145 to Promote Esophageal Squamous Cell Carcinoma Cell Invasion and Migration. Cancer Biother Radiopharm 2020;35:66-71. [PMID: 31702393 DOI: 10.1089/cbr.2019.2926] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
16 Piñerúa-Gonsálvez JF, Zambrano-Infantino RDC, Benítez S. CHROMOENDOSCOPY USING TOLUIDINE BLUE PLUS LUGOL'S SOLUTION FOR EARLY DIAGNOSIS OF ESOPHAGEAL PREMALIGNANT LESIONS AND SUPERFICIAL NEOPLASMS IN HIGH-RISK PATIENTS. Arq Gastroenterol 2019;56:41-4. [PMID: 31141072 DOI: 10.1590/S0004-2803.201900000-01] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Lu J, Sun XD, Yang X, Tang XY, Qin Q, Zhu HC, Cheng HY, Sun XC. Impact of PET/CT on radiation treatment in patients with esophageal cancer: A systematic review. Crit Rev Oncol Hematol 2016;107:128-37. [PMID: 27823640 DOI: 10.1016/j.critrevonc.2016.08.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
18 Sathornviriyapong S, Matsuda A, Miyashita M, Matsumoto S, Sakurazawa N, Kawano Y, Yamada M, Uchida E. Impact of Neoadjuvant Chemoradiation on Short-Term Outcomes for Esophageal Squamous Cell Carcinoma Patients: A Meta-analysis. Ann Surg Oncol 2016;23:3632-40. [PMID: 27278203 DOI: 10.1245/s10434-016-5298-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
19 Huang Y, Feng JF. Low preoperative lymphocyte to monocyte ratio predicts poor cancer-specific survival in patients with esophageal squamous cell carcinoma. Onco Targets Ther 2015;8:137-45. [PMID: 25609981 DOI: 10.2147/OTT.S73794] [Cited by in Crossref: 9] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
20 Zhang T, Shen H, Dong W, Qu X, Liu Q, Du J. Antitumor effects and molecular mechanisms of figitumumab, a humanized monoclonal antibody to IGF-1 receptor, in esophageal carcinoma. Sci Rep 2014;4:6855. [PMID: 25358597 DOI: 10.1038/srep06855] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
21 Maes S, Sharma P, Bisschops R. Review: Surveillance of patients with Barrett oesophagus. Best Pract Res Clin Gastroenterol. 2016;30:901-912. [PMID: 27938785 DOI: 10.1016/j.bpg.2016.09.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
22 Ma XL, Yao H, Wang X, Wei Y, Cao LY, Zhang Q, Zhang L. ILK predicts the efficacy of chemoradiotherapy and the prognosis of patients with esophageal squamous cell carcinoma. Oncol Lett 2019;18:4114-25. [PMID: 31579417 DOI: 10.3892/ol.2019.10768] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Li L, Yue GG, Lee JK, Wong EC, Fung K, Yu J, Lau CB, Chiu PW. Gene expression profiling reveals the plausible mechanisms underlying the antitumor and antimetastasis effects of Andrographis paniculata in esophageal cancer. Phytotherapy Research 2018;32:1388-96. [DOI: 10.1002/ptr.6074] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
24 Yano M, Sugimura K, Miyata H, Motoori M, Tanaka K, Omori T, Ohue M, Sakon M. Randomized Comparison of Gastric Tube Reconstruction With and Without Duodenal Diversion Plus Roux-en-Y Anastomosis After Esophagectomy. Ann Surg 2020;272:48-54. [PMID: 31415003 DOI: 10.1097/SLA.0000000000003557] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
25 Shi L, Chen Q, Ge X. Long intergenic non-coding RNA 00337 confers progression of esophageal cancer by mediating microrna-145-dependent fscn1. FASEB J 2020;34:11431-43. [PMID: 32654289 DOI: 10.1096/fj.202000470] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Chetwood JD, Garg P, Finch P, Gordon M. Systematic review: the etiology of esophageal squamous cell carcinoma in low-income settings. Expert Review of Gastroenterology & Hepatology 2018;13:71-88. [DOI: 10.1080/17474124.2019.1543024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
27 Guo J, Huang J, Zhou Y, Zhou Y, Yu L, Li H, Hou L, Zhu L, Ge D, Zeng Y, Guleng B, Li Q. Germline and somatic variations influence the somatic mutational signatures of esophageal squamous cell carcinomas in a Chinese population. BMC Genomics 2018;19:538. [PMID: 30012096 DOI: 10.1186/s12864-018-4906-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
28 Ma J, Wang L, Li J, Zhang G, Tao H, Li X, Sun D, Hu Y. Swainsonine Inhibits Invasion and the EMT Process in Esophageal Carcinoma Cells by Targeting Twist1. Oncol Res 2018;26:1207-13. [PMID: 28899457 DOI: 10.3727/096504017X15046134836575] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
29 Cui Y, Xue Y, Dong S, Zhang P. Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma. J Int Med Res 2017;45:1310-7. [PMID: 28587538 DOI: 10.1177/0300060517709370] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
30 Mederos MA, de Virgilio MJ, Shenoy R, Ye L, Toste PA, Mak SS, Booth MS, Begashaw MM, Wilson M, Gunnar W, Shekelle PG, Maggard-Gibbons M, Girgis MD. Comparison of Clinical Outcomes of Robot-Assisted, Video-Assisted, and Open Esophagectomy for Esophageal Cancer: A Systematic Review and Meta-analysis. JAMA Netw Open 2021;4:e2129228. [PMID: 34724556 DOI: 10.1001/jamanetworkopen.2021.29228] [Reference Citation Analysis]
31 Naffouje SA, Salloum RH, Khalaf Z, Salti GI. Outcomes of Open Versus Minimally Invasive Ivor-Lewis Esophagectomy for Cancer: A Propensity-Score Matched Analysis of NSQIP Database. Ann Surg Oncol. 2019;. [PMID: 30927192 DOI: 10.1245/s10434-019-07319-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
32 Wang H, Zhou J, He Q, Dong Y, Liu Y. Azidothymidine inhibits cell growth and telomerase activity and induces DNA damage in human esophageal cancer. Mol Med Rep 2017;15:4055-60. [PMID: 28487971 DOI: 10.3892/mmr.2017.6549] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
33 Hussain A, Dulay P, Rivera MN, Aramouni C, Saxena V. Neoplastic Pathogenesis Associated with Cigarette Carcinogens. Cureus 2019;11:e3955. [PMID: 30956908 DOI: 10.7759/cureus.3955] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
34 Ma W, Su H, Cheetham AG, Zhang W, Wang Y, Kan Q, Cui H. Synergistic antitumor activity of a self-assembling camptothecin and capecitabine hybrid prodrug for improved efficacy. Journal of Controlled Release 2017;263:102-11. [DOI: 10.1016/j.jconrel.2017.01.015] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 7.6] [Reference Citation Analysis]
35 Gao S, Li S, Duan X, Gu Z, Ma Z, Yuan X, Feng X, Wang H. Inhibition of glycogen synthase kinase 3 beta (GSK3β) suppresses the progression of esophageal squamous cell carcinoma by modifying STAT3 activity. Mol Carcinog 2017;56:2301-16. [PMID: 28574599 DOI: 10.1002/mc.22685] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
36 Feng JF, Wang L, Jiang YH, Yang X. C-Reactive Protein to Prealbumin Ratio (CPR): A Novel Inflammatory-Nutritional Prognostic Factor for Predicting Cancer-Specific Survival (CSS) and Overall Survival (OS) in Patients with Resectable Esophageal Squamous Cell Carcinoma. J Oncol 2019;2019:4359103. [PMID: 31379941 DOI: 10.1155/2019/4359103] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
37 Li YY, Du LB, Hu XQ, Jaiswal S, Gu SY, Gu YX, Dong HJ. A suggested framework for conducting esophageal cancer screening in China. J Dig Dis 2018;19:722-9. [PMID: 30375169 DOI: 10.1111/1751-2980.12675] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
38 Wang X, Li X, Cheng H, Zhang B, Zhong H, Wang R, Zhong B, Cao Q. Single-Port Inflatable Mediastinoscopy Combined With Laparoscopic-Assisted Small Incision Surgery for Radical Esophagectomy Is an Effective and Safe Treatment for Esophageal Cancer. J Gastrointest Surg 2019;23:1533-40. [PMID: 30635830 DOI: 10.1007/s11605-018-04069-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
39 Polyzos SA, Zeglinas C, Artemaki F, Doulberis M, Kazakos E, Katsinelos P, Kountouras J. Helicobacter pylori infection and esophageal adenocarcinoma: a review and a personal view. Ann Gastroenterol 2018;31:8-13. [PMID: 29333062 DOI: 10.20524/aog.2017.0213] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
40 Qiao Z, Cheng Y, Liu S, Ma Z, Li S, Zhang W. Casticin inhibits esophageal cancer cell proliferation and promotes apoptosis by regulating mitochondrial apoptotic and JNK signaling pathways. Naunyn Schmiedebergs Arch Pharmacol 2019;392:177-87. [PMID: 30448926 DOI: 10.1007/s00210-018-1574-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
41 Tsukamoto M, Naito M, Wakai K, Naito T, Kojima M, Umemura O, Yokota M, Hanada N, Kawamura T. Tooth brushing, tooth loss, and risk of upper aerodigestive tract cancer: a cohort study of Japanese dentisits. Nagoya J Med Sci 2021;83:331-41. [PMID: 34239181 DOI: 10.18999/nagjms.83.2.331] [Reference Citation Analysis]
42 Hu D, Peng F, Lin X, Chen G, Liang B, Li C, Zhang H, Liao X, Lin J, Zheng X, Niu W. The elevated preoperative fasting blood glucose predicts a poor prognosis in patients with esophageal squamous cell carcinoma: The Fujian prospective investigation of cancer (FIESTA) study. Oncotarget 2016;7:65247-56. [PMID: 27533454 DOI: 10.18632/oncotarget.11247] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
43 Li Z, Cheng J, Zhang Y, Wen S, Lv H, Xu Y, Zhu Y, Zhang Z, Mu D, Tian Z. Comparison of Up-Front Minimally Invasive Esophagectomy versus Open Esophagectomy on Quality of Life for Esophageal Squamous Cell Cancer. Curr Oncol 2021;28:693-701. [PMID: 33503901 DOI: 10.3390/curroncol28010068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Liu FT, Gao H, Wu CW, Zhu ZM. The association of plasma fibrinogen with clinicopathological features and prognosis in esophageal cancer patients. Oncotarget 2017;8:93029-38. [PMID: 29190975 DOI: 10.18632/oncotarget.21746] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
45 Tratnjek L, Sibinovska N, Kralj S, Makovec D, Kristan K, Kreft ME. Standardization of esophageal adenocarcinoma in vitro model and its applicability for model drug testing. Sci Rep 2021;11:6664. [PMID: 33758229 DOI: 10.1038/s41598-021-85530-w] [Reference Citation Analysis]
46 Kaneko MK, Itai S, Yamada S, Kato Y. 47-mG2a: A Mouse IgG2a-Type of PcMab-47 Useful for Detecting Podocalyxin in Esophageal Cancers by Immunohistochemistry. Monoclon Antib Immunodiagn Immunother 2018;37:158-61. [PMID: 29630446 DOI: 10.1089/mab.2018.0003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
47 Zhang Y, Han Y, Gan Q, Xiang J, Jin R, Chen K, Che J, Hang J, Li H. Early Outcomes of Robot-Assisted Versus Thoracoscopic-Assisted Ivor Lewis Esophagectomy for Esophageal Cancer: A Propensity Score-Matched Study. Ann Surg Oncol 2019;26:1284-91. [PMID: 30843161 DOI: 10.1245/s10434-019-07273-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
48 Fatima N, Zaman MU, Zaman A, Zaman U, Tahseen R, Zaman S. Staging and Response Evaluation to Neo-Adjuvant Chemoradiation in Esophageal Cancers Using 18FDG PET/ CT with Standardized Protocol. Asian Pac J Cancer Prev 2019;20:2003-8. [PMID: 31350957 DOI: 10.31557/APJCP.2019.20.7.2003] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
49 Lin L, Lin DC. Biological Significance of Tumor Heterogeneity in Esophageal Squamous Cell Carcinoma. Cancers (Basel) 2019;11:E1156. [PMID: 31409002 DOI: 10.3390/cancers11081156] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
50 Chen MF, Hsieh CC, Chen PT, Lu MS. Role of Nutritional Status in the Treatment Outcome for Esophageal Squamous Cell Carcinoma. Nutrients 2021;13:2997. [PMID: 34578883 DOI: 10.3390/nu13092997] [Reference Citation Analysis]
51 Kosovec JE, Zaidi AH, Kelly LA, Rotoloni CL, Vytlacil C, DiCarlo C, Matsui D, Komatsu Y, Boyd NH, Omstead A. Preclinical Study of AUY922, a Novel Hsp90 Inhibitor, in the Treatment of Esophageal Adenocarcinoma. Ann Surg. 2016;264:297-304. [PMID: 26445473 DOI: 10.1097/sla.0000000000001467] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
52 Kauppila JH, Mattsson F, Brusselaers N, Lagergren J. Prognosis of oesophageal adenocarcinoma and squamous cell carcinoma following surgery and no surgery in a nationwide Swedish cohort study. BMJ Open. 2018;8:e021495. [PMID: 29748347 DOI: 10.1136/bmjopen-2018-021495] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 6.5] [Reference Citation Analysis]
53 Hajelssedig OE, Zorron Cheng Tao Pu L, Thompson JY, Lord A, El Sayed I, Meyer C, Shaukat Ali F, Abdulazeem HM, Kheir AO, Siepmann T, Singh R. Diagnostic accuracy of narrow-band imaging endoscopy with targeted biopsies compared with standard endoscopy with random biopsies in patients with Barrett's esophagus: A systematic review and meta-analysis. J Gastroenterol Hepatol 2021. [PMID: 34121232 DOI: 10.1111/jgh.15577] [Reference Citation Analysis]
54 Leung PK, Lee LC, Ip TK, Liu HW, Yiu SM, Lee NP, Lo KK. Luminescent rhenium(I) perfluorobiphenyl complexes as site-specific labels for peptides to afford photofunctional bioconjugates. Chem Commun (Camb) 2021;57:11256-9. [PMID: 34633395 DOI: 10.1039/d1cc04740j] [Reference Citation Analysis]
55 Zhao RH, Zhu CH, Li XK, Cao W, Zong H, Cao XG, Hu HY. BC200 LncRNA a potential predictive marker of poor prognosis in esophageal squamous cell carcinoma patients. Onco Targets Ther 2016;9:2221-6. [PMID: 27143917 DOI: 10.2147/OTT.S99401] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
56 Vashisht A, Trebak M, Motiani RK. STIM and Orai proteins as novel targets for cancer therapy. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis. Am J Physiol Cell Physiol 2015;309:C457-69. [PMID: 26017146 DOI: 10.1152/ajpcell.00064.2015] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 9.4] [Reference Citation Analysis]
57 Guo W, Liu S, Dong Z, Guo Y, Ding C, Shen S, Liang J, Shan B. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma. Clin Exp Metastasis 2018;35:53-68. [PMID: 29524086 DOI: 10.1007/s10585-018-9881-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
58 Londono R, Badylak SF. Regenerative Medicine Strategies for Esophageal Repair. Tissue Eng Part B Rev 2015;21:393-410. [PMID: 25813694 DOI: 10.1089/ten.TEB.2015.0014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
59 Sato N, Fujishima F, Nakamura Y, Aoyama Y, Onodera Y, Ozawa Y, Ito K, Ishida H, Kamei T, Watanabe M, Sasano H. Myosin 5a regulates tumor migration and epithelial-mesenchymal transition in esophageal squamous cell carcinoma: utility as a prognostic factor. Human Pathology 2018;80:113-22. [DOI: 10.1016/j.humpath.2018.06.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
60 Vingeliene S, Chan DS, Aune D, Vieira AR, Polemiti E, Stevens C, Abar L, Rosenblatt DN, Greenwood DC, Norat T. An update of the WCRF/AICR systematic literature review on esophageal and gastric cancers and citrus fruits intake. Cancer Causes Control 2016;27:837-51. [PMID: 27153845 DOI: 10.1007/s10552-016-0755-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
61 Molina JC, Al-Hinai A, Gosseling-Tardif A, Bouchard P, Spicer J, Mulder D, Mueller CL, Ferri LE. Multivisceral Resection for Locally Advanced Gastric and Gastroesophageal Junction Cancers-11-Year Experience at a High-Volume North American Center. J Gastrointest Surg. 2019;23:43-50. [PMID: 29663302 DOI: 10.1007/s11605-018-3746-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
62 Shen WJ, Zhang F, Zhao X, Xu J. LncRNAs and Esophageal Squamous Cell Carcinoma - Implications for Pathogenesis and Drug Development. J Cancer 2016;7:1258-64. [PMID: 27390601 DOI: 10.7150/jca.14869] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
63 Zhao CL, Yu S, Wang SH, Li SG, Wang ZJ, Han SN. Characterization of cluster of differentiation 47 expression and its potential as a therapeutic target in esophageal squamous cell cancer. Oncol Lett. 2018;15:2017-2023. [PMID: 29399202 DOI: 10.3892/ol.2017.7447] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
64 Mortensen MB. Novel imaging strategies for upper gastrointestinal tract cancers. Expert Rev Gastroenterol Hepatol 2015;9:295-303. [PMID: 25220101 DOI: 10.1586/17474124.2015.959928] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
65 Lee HN, Kim JI, Shin SY, Kim DH, Kim C, Hong IK. Combined CT texture analysis and nodal axial ratio for detection of nodal metastasis in esophageal cancer. Br J Radiol 2020;93:20190827. [PMID: 32242741 DOI: 10.1259/bjr.20190827] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
66 Golyan FF, Abbaszadegan MR, Forghanifard MM. TWIST1, MMP-21, and HLAG-1 co-overexpression is associated with ESCC aggressiveness. J Cell Biochem 2019;120:14838-46. [PMID: 31016793 DOI: 10.1002/jcb.28745] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
67 Tsang ES, Lim HJ, Renouf DJ, Davies JM, Loree JM, Gill S. Real-world treatment attrition rates in advanced esophagogastric cancer. World J Gastroenterol 2020; 26(39): 6027-6036 [PMID: 33132652 DOI: 10.3748/wjg.v26.i39.6027] [Reference Citation Analysis]
68 Wu I, Weng Y, Lu M, Jen C, Fedorov VE, Chen WC, Wu MT, Kuo C, Wang H. Nano-structure ZnO/Cu_2O photoelectrochemical and self-powered biosensor for esophageal cancer cell detection. Opt Express 2017;25:7689. [DOI: 10.1364/oe.25.007689] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
69 Rochefort MM, Wee JO. Going with the Flowmetry: How Doppler Assessment Helps Predict the Formation of Anastomotic Strictures After Esophagectomy. Dig Dis Sci 2019;64:3038-9. [PMID: 30830523 DOI: 10.1007/s10620-019-05565-y] [Reference Citation Analysis]
70 Blackham AU, H Naqvi SM, Schell MJ, Jin W, Gangi A, Almhanna K, Fontaine JP, Hoffe SE, Frakes J, Venkat P, Pimiento JM. Recurrence patterns and associated factors of locoregional failure following neoadjuvant chemoradiation and surgery for esophageal cancer. J Surg Oncol 2018;117:150-9. [PMID: 28833197 DOI: 10.1002/jso.24808] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
71 Lagarde SM, Phillips AW, Navidi M, Disep B, Griffin SM. Clinical outcomes and benefits for staging of surgical lymph node mapping after esophagectomy. Diseases of the Esophagus 2017;30:1-7. [DOI: 10.1093/dote/dox086] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
72 Hwang J, Haque MA, Suzuki H, Dijke PT, Kato M. THG-1 suppresses SALL4 degradation to induce stemness genes and tumorsphere formation through antagonizing NRBP1 in squamous cell carcinoma cells. Biochem Biophys Res Commun 2020;523:307-14. [PMID: 31864704 DOI: 10.1016/j.bbrc.2019.11.149] [Reference Citation Analysis]
73 Geßner AL, Borkowetz A, Baier M, Göhlert A, Wilhelm TJ, Thumbs A, Borgstein E, Jansen L, Beer K, Mothes H, Dürst M. Detection of HPV16 in Esophageal Cancer in a High-Incidence Region of Malawi. Int J Mol Sci 2018;19:E557. [PMID: 29439548 DOI: 10.3390/ijms19020557] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
74 Chen P, Zhang JY, Sha BB, Ma YE, Hu T, Ma YC, Sun H, Shi JX, Dong ZM, Li P. Luteolin inhibits cell proliferation and induces cell apoptosis via down-regulation of mitochondrial membrane potential in esophageal carcinoma cells EC1 and KYSE450. Oncotarget 2017;8:27471-80. [PMID: 28460467 DOI: 10.18632/oncotarget.15832] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 8.0] [Reference Citation Analysis]
75 Omidvari AH, Ali A, Hazelton WD, Kroep S, Lee M, Naber SK, Lauren BN, Ostvar S, Richmond E, Kong CY, Rubenstein JH, Lansdorp-Vogelaar I, Luebeck G, Hur C, Inadomi J. Optimizing Management of Patients With Barrett's Esophagus and Low-Grade or No Dysplasia Based on Comparative Modeling. Clin Gastroenterol Hepatol 2020;18:1961-9. [PMID: 31816445 DOI: 10.1016/j.cgh.2019.11.058] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
76 Mao S, Li Y, Lu Z, Che Y, Sun S, Huang J, Lei Y, Wang X, Liu C, Zheng S, Zang R, Li N, Li J, Sun N, He J. Survival-associated alternative splicing signatures in esophageal carcinoma. Carcinogenesis 2019;40:121-30. [PMID: 30304323 DOI: 10.1093/carcin/bgy123] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 7.7] [Reference Citation Analysis]
77 Depypere L, Lerut T, Moons J, Coosemans W, Decker G, Van Veer H, De Leyn P, Nafteux P. Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road. Dis Esophagus 2017;30:1-8. [PMID: 27704661 DOI: 10.1111/dote.12508] [Cited by in Crossref: 5] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
78 Thoen H, Ceelen W, Boterberg T, Van Daele E, Pattyn P. Tumor recurrence and in-field control after multimodality treatment of locally advanced esophageal cancer. Radiotherapy and Oncology 2015;115:16-21. [DOI: 10.1016/j.radonc.2015.03.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
79 Warnecke-Eberz U, Plum P, Schweinsberg V, Drebber U, Bruns CJ, Müller DT, Hölscher AH, Bollschweiler E. Neoadjuvant chemoradiation changes podoplanin expression in esophageal cancer patients. World J Gastroenterol 2020; 26(23): 3236-3248 [PMID: 32684738 DOI: 10.3748/wjg.v26.i23.3236] [Reference Citation Analysis]
80 Kuwai T, Yamaguchi T, Imagawa H, Miura R, Sumida Y, Takasago T, Miyasako Y, Nishimura T, Iio S, Yamaguchi A, Kouno H, Kohno H, Ishaq S. Endoscopic submucosal dissection for early esophageal neoplasms using the stag beetle knife. World J Gastroenterol 2018; 24(15): 1632-1640 [PMID: 29686470 DOI: 10.3748/wjg.v24.i15.1632] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
81 Koopman T, de Bock GH, Buikema HJ, Smits MM, Louwen M, Hage M, Imholz ALT, van der Vegt B. Digital image analysis of HER2 immunohistochemistry in gastric- and oesophageal adenocarcinoma: a validation study on biopsies and surgical specimens. Histopathology 2018;72:191-200. [PMID: 28746978 DOI: 10.1111/his.13322] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
82 Liang D, Li D, Liu J, Jin J, Shi J, Shan B, He Y. Trends and Patterns of Cancer Mortality in North China (Hebei Province), 1973-2013. Sci Rep 2018;8:311. [PMID: 29321605 DOI: 10.1038/s41598-017-18715-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
83 Barbetta A, Sihag S, Nobel T, Hsu M, Tan KS, Bains M, Jones DR, Molena D. Patterns and risk of recurrence in patients with esophageal cancer with a pathologic complete response after chemoradiotherapy followed by surgery. J Thorac Cardiovasc Surg 2019;157:1249-1259.e5. [PMID: 30655068 DOI: 10.1016/j.jtcvs.2018.09.136] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
84 Zaeran E, Azizmohammad Looha M, Amini P, Azimi T, Mahmoudi M; Modeling in Health Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran, Dept. of Biostatistics, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Science, Tehran, Iran., Reproductive Epidemiology Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran, Faculty of Public Health, University of Alberta, Edmonton, Alberta, Canada, Dept. of Epidemiology and Biostatistics, Faculty of Public Health, Tehran University of Medical Sciences, Tehran, Iran. Evaluating Long-term survival of patients with esophageal cancer using parametric non-mixture cure rate models. J Adv Med Biomed Res 2019;27:43-50. [DOI: 10.30699/jambs.27.120.43] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
85 Chua T, Fukami N. Upfront endoscopic submucosal dissection for superficial squamous cell carcinoma is superior to upfront surgical therapy. Gastrointest Endosc 2018;88:634-6. [PMID: 30217240 DOI: 10.1016/j.gie.2018.07.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
86 Wang J, Wei N, Lu Y, Zhang X, Jiang N. Mediastinoscopy-assisted esophagectomy for T2 middle and lower thoracic esophageal squamous cell carcinoma patients. World J Surg Oncol 2018;16:58. [PMID: 29548327 DOI: 10.1186/s12957-018-1361-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
87 Feng JF, Sheng C, Zhao Q, Chen P. Prognostic value of mean platelet volume/platelet count ratio in patients with resectable esophageal squamous cell carcinoma: a retrospective study. PeerJ 2019;7:e7246. [PMID: 31328033 DOI: 10.7717/peerj.7246] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
88 Xi S, Inchauste S, Guo H, Shan J, Xiao Z, Xu H, Miettenen M, Zhang MR, Hong JA, Raiji MT, Altorki NK, Casson AG, Beer DG, Robles AI, Bowman ED, Harris CC, Steinberg SM, Schrump DS. Cigarette smoke mediates epigenetic repression of miR-217 during esophageal adenocarcinogenesis. Oncogene 2015;34:5548-59. [PMID: 25703328 DOI: 10.1038/onc.2015.10] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
89 Münch S, Heinrich C, Habermehl D, Oechsner M, Combs SE, Duma MN. Primary radio(chemo)therapy for esophageal cancer in elderly patients: are efficiency and toxicity comparable with younger patients? Eur J Med Res 2017;22:24. [PMID: 28683820 DOI: 10.1186/s40001-017-0265-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
90 Amorim CA, De Souza LP, Moreira JP, Luiz RR, De V Carneiro AJ, De Souza HSP. Geographic distribution and time trends of esophageal cancer in Brazil from 2005 to 2015. Mol Clin Oncol 2019;10:631-8. [PMID: 31086670 DOI: 10.3892/mco.2019.1842] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
91 Abbas H, Ghazanfar H, Ul Hussain AN, Baiomi A, Ihimoyan A. Atypical Presentation of Esophageal Squamous Cell Carcinoma Masquerading as Diffuse Severe Esophagitis. Case Rep Gastroenterol 2021;15:533-8. [PMID: 34616252 DOI: 10.1159/000517129] [Reference Citation Analysis]
92 Samiei H, Sadighi-Moghaddam B, Mohammadi S, Gharavi A, Abdolmaleki S, Khosravi A, Kokhaei P, Bazzazi H, Memarian A. Dysregulation of helper T lymphocytes in esophageal squamous cell carcinoma (ESCC) patients is highly associated with aberrant production of miR-21. Immunol Res 2019;67:212-22. [PMID: 31278653 DOI: 10.1007/s12026-019-09079-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
93 Hess NR, Rizk NP, Luketich JD, Sarkaria IS. Preservation of replaced left hepatic artery during robotic-assisted minimally invasive esophagectomy: A case series. Int J Med Robot 2017;13. [PMID: 28251793 DOI: 10.1002/rcs.1802] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
94 Encinas de la Iglesia J, Corral de la Calle MA, Fernández Pérez GC, Ruano Pérez R, Álvarez Delgado A. Esophageal cancer: anatomic particularities, staging, and imaging techniques. Radiologia 2016;58:352-65. [PMID: 27469407 DOI: 10.1016/j.rx.2016.06.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
95 Song EY, Frakes JM, Extermann M, Klocksieben F, Mehta R, Saeed S, Hoffe SE, Pimiento JM. Clinical Factors and Outcomes of Octogenarians Receiving Curative Surgery for Esophageal Cancer. J Surg Res 2020;251:100-6. [PMID: 32114211 DOI: 10.1016/j.jss.2020.01.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
96 Min Q, Wang Y, Wu Q, Li X, Teng H, Fan J, Cao Y, Fan P, Zhan Q. Genomic and epigenomic evolution of acquired resistance to combination therapy in esophageal squamous cell carcinoma. JCI Insight 2021;6:150203. [PMID: 34494553 DOI: 10.1172/jci.insight.150203] [Reference Citation Analysis]
97 Sukocheva OA, Furuya H, Ng ML, Friedemann M, Menschikowski M, Tarasov VV, Chubarev VN, Klochkov SG, Neganova ME, Mangoni AA, Aliev G, Bishayee A. Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target. Pharmacol Ther. 2020;207:107464. [PMID: 31863815 DOI: 10.1016/j.pharmthera.2019.107464] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
98 Sun S, Yu H, Wang H, Zhang H, Wu X, Wang J, Chang J. Phase II Study of S-1 plus Cisplatin as First-Line Therapy in Patients with Metastatic Esophageal Carcinoma. Oncol Res Treat 2019;42:115-22. [PMID: 30799403 DOI: 10.1159/000495700] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
99 Jain G, Kumar C, Damle N, Kumar M, Ranjan A, Tanwar P. Esophageal Squamous Cell Carcinoma Metastatic to Umbilicus: a Case Report with Review of Literature. J Gastrointest Cancer 2019;50:1018-21. [PMID: 30552555 DOI: 10.1007/s12029-018-00185-7] [Reference Citation Analysis]
100 Feng JF, Chen S, Yang X. Combination of c-reactive protein and squamous cell carcinoma antigen in predicting postoperative prognosis for patients with squamous cell carcinoma of the esophagus. Oncotarget 2017;8:63132-9. [PMID: 28968977 DOI: 10.18632/oncotarget.18667] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
101 Li S, Jiang S, Jiang W, Zhou Y, Shen XY, Luo T, Kong LP, Wang HQ. Anticancer effects of crocetin in human esophageal squamous cell carcinoma KYSE-150 cells. Oncol Lett 2015;9:1254-60. [PMID: 25663893 DOI: 10.3892/ol.2015.2869] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
102 Xu WY, Yang XB, Wang WQ, Bai Y, Long JY, Lin JZ, Xiong JP, Zheng YC, He XD, Zhao HT, Sang XT. Prognostic impact of the red cell distribution width in esophageal cancer patients: A systematic review and meta-analysis. World J Gastroenterol 2018; 24(19): 2120-2129 [PMID: 29785080 DOI: 10.3748/wjg.v24.i19.2120] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
103 Wu K, Zhang C, Zhang C, Dai D. A Novel Three-miRNA Signature Identified Using Bioinformatics Predicts Survival in Esophageal Carcinoma. Biomed Res Int 2020;2020:5973082. [PMID: 32104700 DOI: 10.1155/2020/5973082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
104 Wang Y, Peng J, Li Y, Luo H, Huang G, Luo S, Yin X, Song J. Association between tooth loss and risk of oesophageal cancer: a dose-response meta-analysis. Springerplus 2016;5:1020. [PMID: 27441139 DOI: 10.1186/s40064-016-2711-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
105 van den Boorn HG, Abu-Hanna A, Ter Veer E, van Kleef JJ, Lordick F, Stahl M, Ajani JA, Guimbaud R, Park SH, Dutton SJ, Bang YJ, Boku N, Mohammad NH, Sprangers MAG, Verhoeven RHA, Zwinderman AH, van Oijen MGH, van Laarhoven HWM. SOURCE: A Registry-Based Prediction Model for Overall Survival in Patients with Metastatic Oesophageal or Gastric Cancer. Cancers (Basel) 2019;11:E187. [PMID: 30764578 DOI: 10.3390/cancers11020187] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
106 Greene CL, Mcfadden PM. The surgeon's perspective on oesophageal disease, and what it means to pathologists. J Clin Pathol 2014;67:913-8. [DOI: 10.1136/jclinpath-2014-202518] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
107 Wong KC, Chen J, Zhang J, Lin J, Yan S, Zhang S, Li X, Liang C, Peng C, Lin Q, Kwong S, Yu J. Early Cancer Detection from Multianalyte Blood Test Results. iScience 2019;15:332-41. [PMID: 31103852 DOI: 10.1016/j.isci.2019.04.035] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
108 Bograd AJ, Molena D. Minimally invasive esophagectomy. Curr Probl Surg 2021;58:100984. [PMID: 34629156 DOI: 10.1016/j.cpsurg.2021.100984] [Reference Citation Analysis]
109 Haj Mohammad N, Walter AW, van Oijen MG, Hulshof MC, Bergman JJ, Anderegg MC, van Berge Henegouwen MI, Henselmans I, Sprangers MA, van Laarhoven HW. Burden of spousal caregivers of stage II and III esophageal cancer survivors 3 years after treatment with curative intent. Support Care Cancer 2015;23:3589-98. [PMID: 25894882 DOI: 10.1007/s00520-015-2727-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
110 Katz H, Saad RE, Denning K, Pacioles TO. A Rare Case of Esophageal Adenocarcinoma with Urinary Bladder Metastasis. Case Rep Gastrointest Med 2017;2017:9343896. [PMID: 28642830 DOI: 10.1155/2017/9343896] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
111 Zhou C, Zhang L, Xu P. Growth inhibition and chemo-radiosensitization of esophageal squamous cell carcinoma by survivin-shRNA lentivirus transfection. Oncol Lett 2018;16:4813-20. [PMID: 30250546 DOI: 10.3892/ol.2018.9280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
112 Gao S, Li J, Feng X, Shi S, He J. Characteristics and Surgical Outcomes for Primary Malignant Melanoma of the Esophagus. Sci Rep 2016;6:23804. [PMID: 27033424 DOI: 10.1038/srep23804] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
113 Zhang D, Zhou X, Bao W, Chen Y, Cheng L, Qiu G, Sheng L, Ji Y, Du X. Plasma fibrinogen levels are correlated with postoperative distant metastasis and prognosis in esophageal squamous cell carcinoma. Oncotarget. 2015;6:38410-38420. [PMID: 26334098 DOI: 10.18632/oncotarget.4800] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
114 Anderson BW, Ahlquist DA. Molecular Detection of Gastrointestinal Neoplasia: Innovations in Early Detection and Screening. Gastroenterol Clin North Am 2016;45:529-42. [PMID: 27546847 DOI: 10.1016/j.gtc.2016.04.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
115 Jefremow A, Neurath MF, Waldner MJ. CRISPR/Cas9 in Gastrointestinal Malignancies. Front Cell Dev Biol 2021;9:727217. [PMID: 34912798 DOI: 10.3389/fcell.2021.727217] [Reference Citation Analysis]
116 Hujanen R, Almahmoudi R, Karinen S, Nwaru BI, Salo T, Salem A. Vasculogenic Mimicry: A Promising Prognosticator in Head and Neck Squamous Cell Carcinoma and Esophageal Cancer? A Systematic Review and Meta-Analysis. Cells 2020;9:E507. [PMID: 32102317 DOI: 10.3390/cells9020507] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
117 Takahashi K, Nishikawa K, Furukawa K, Tanishima Y, Ishikawa Y, Kurogochi T, Yuda M, Tanaka Y, Matsumoto A, Mitsumori N, Ikegami T. Prognostic Significance of Preoperative Osteopenia in Patients Undergoing Esophagectomy for Esophageal Cancer. World J Surg 2021;45:3119-28. [PMID: 34152448 DOI: 10.1007/s00268-021-06199-w] [Reference Citation Analysis]
118 Huang H, Xu Y, Guo Z, Chen X, Ji S, Xu Z. MicroRNA-133b inhibits cell proliferation and promotes apoptosis by targeting cullin 4B in esophageal squamous cell carcinoma. Exp Ther Med 2018;15:3743-50. [PMID: 29581734 DOI: 10.3892/etm.2018.5906] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
119 Gao Z, Liu H, Shi Y, Yin L, Zhu Y, Liu R. Identification of Cancer Stem Cell Molecular Markers and Effects of hsa-miR-21-3p on Stemness in Esophageal Squamous Cell Carcinoma. Cancers 2019;11:518. [DOI: 10.3390/cancers11040518] [Reference Citation Analysis]
120 Zhu ZJ, Qi Z, Zhang J, Xue WH, Li LF, Shen ZB, Li ZY, Yuan YL, Wang WB, Zhao J. Untargeted Metabolomics Analysis of Esophageal Squamous Cell Carcinoma Discovers Dysregulated Metabolic Pathways and Potential Diagnostic Biomarkers. J Cancer 2020;11:3944-54. [PMID: 32328198 DOI: 10.7150/jca.41733] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
121 Gao Z, Liu H, Shi Y, Yin L, Zhu Y, Liu R. Identification of Cancer Stem Cell Molecular Markers and Effects of hsa-miR-21-3p on Stemness in Esophageal Squamous Cell Carcinoma. Cancers (Basel). 2019;11. [PMID: 30979011 DOI: 10.3390/cancers11040518] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
122 Jensen T, Blanchette A, Vadasz S, Dave A, Canfarotta M, Sayej WN, Finck C. Biomimetic and synthetic esophageal tissue engineering. Biomaterials 2015;57:133-41. [DOI: 10.1016/j.biomaterials.2015.04.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
123 Zarean E, Amini P, Yaseri M, Hajihosseini M, Azimi T, Mahmoudi M. Determining Risk Factors for Gastric and Esophageal Cancers between 2009-2015 in East-Azarbayjan, Iran Using Parametric Survival Models. Asian Pac J Cancer Prev 2019;20:443-9. [PMID: 30803206 DOI: 10.31557/APJCP.2019.20.2.443] [Reference Citation Analysis]
124 Yang Y, Fan X, Ren Y, Wu K, Tian X, Wen F, Liu D, Fan Y, Zhao S. SOX2-Upregulated microRNA-30e Promotes the Progression of Esophageal Cancer via Regulation of the USP4/SMAD4/CK2 Axis. Mol Ther Nucleic Acids 2021;23:200-14. [PMID: 33376627 DOI: 10.1016/j.omtn.2020.10.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
125 Orazbayev BA, Musulmanbekov K, Bukenov A. Analysis of Treatment Results of the Thoracic Part of Oesophageal Cancer. Open Access Maced J Med Sci 2019;7:82-7. [PMID: 30740166 DOI: 10.3889/oamjms.2019.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
126 Wu BL, Wang D, Bai WJ, Zhang F, Zhao X, Yi Y, Zhang T, Shen WJ, Li EM, Xu LY, Xu JZ. An integrative framework to identify cell death-related microRNAs in esophageal squamous cell carcinoma. Oncotarget 2016;7:56758-66. [PMID: 27462775 DOI: 10.18632/oncotarget.10779] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
127 Izadifar Z, Izadifar Z, Chapman D, Babyn P. An Introduction to High Intensity Focused Ultrasound: Systematic Review on Principles, Devices, and Clinical Applications.J Clin Med. 2020;9. [PMID: 32046072 DOI: 10.3390/jcm9020460] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 13.5] [Reference Citation Analysis]
128 Wang D, Plukker J, Coppes R. Cancer stem cells with increased metastatic potential as a therapeutic target for esophageal cancer. Seminars in Cancer Biology 2017;44:60-6. [DOI: 10.1016/j.semcancer.2017.03.010] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
129 Niyaz M, Ainiwaer J, Abudureheman A, Zhang L, Sheyhidin I, Turhong A, Cai R, Hou Z, Awut E. Association between TP53 gene deletion and protein expression in esophageal squamous cell carcinoma and its prognostic significance. Oncol Lett 2020;20:1855-65. [PMID: 32724429 DOI: 10.3892/ol.2020.11709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
130 Falvey CM, O'Donovan TR, El-Mashed S, Nyhan MJ, O'Reilly S, McKenna SL. UBE2L6/UBCH8 and ISG15 attenuate autophagy in esophageal cancer cells. Oncotarget 2017;8:23479-91. [PMID: 28186990 DOI: 10.18632/oncotarget.15182] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
131 Ma F, Laster K, Nie W, Liu F, Kim DJ, Lee MH, Bai R, Yang R, Liu K, Dong Z. Heterogeneity Analysis of Esophageal Squamous Cell Carcinoma in Cell Lines, Tumor Tissues and Patient-Derived Xenografts. J Cancer 2021;12:3930-44. [PMID: 34093800 DOI: 10.7150/jca.52286] [Reference Citation Analysis]
132 Kouzu K, Tsujimoto H, Ishibashi Y, Shinada H, Oikawa I, Kishi Y, Shinomiya N, Ueno H. Preoperative Fall Risk Assessment Score as a Prognostic Factor in Esophageal Cancer Patients after Esophagectomy. J Clin Med 2021;10:5966. [PMID: 34945262 DOI: 10.3390/jcm10245966] [Reference Citation Analysis]
133 Chueca E, Valero A, Hördnler C, Puertas A, Carrera P, García-González MA, Strunk M, Lanas A, Piazuelo E. Quantitative analysis of p16 methylation in Barrett's carcinogenesis. Ann Diagn Pathol 2020;47:151554. [PMID: 32570024 DOI: 10.1016/j.anndiagpath.2020.151554] [Reference Citation Analysis]
134 Ahmad SZ, Battoo AJ, Haji AG, Naveed S, Qurieshi MA, Mir AW, Malik TR. Patterns of Failure After Trimodal Treatment in Esophageal Squamous Cell Carcinoma: Initial Experiences from a High-Risk Endemic Area. Indian J Surg Oncol 2020;11:360-6. [PMID: 33013111 DOI: 10.1007/s13193-020-01164-w] [Reference Citation Analysis]
135 Alcolea MP. Oesophageal Stem Cells and Cancer. Adv Exp Med Biol 2017;1041:187-206. [PMID: 29204834 DOI: 10.1007/978-3-319-69194-7_10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
136 Dislich B, Stein A, Seiler CA, Kröll D, Berezowska S, Zlobec I, Galvan J, Slotta-Huspenina J, Walch A, Langer R. Expression patterns of programmed death-ligand 1 in esophageal adenocarcinomas: comparison between primary tumors and metastases. Cancer Immunol Immunother 2017;66:777-86. [PMID: 28289861 DOI: 10.1007/s00262-017-1982-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
137 Sridhar P, Bhatt M, Qureshi MM, Asokan S, Truong MT, Suzuki K, Mak KS, Litle VR. Esophageal Cancer Presentation, Treatment, and Outcomes Vary With Hospital Safety-Net Burden. The Annals of Thoracic Surgery 2019;107:1472-9. [DOI: 10.1016/j.athoracsur.2018.11.065] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
138 Then EO, Lopez M, Saleem S, Gayam V, Sunkara T, Culliford A, Gaduputi V. Esophageal Cancer: An Updated Surveillance Epidemiology and End Results Database Analysis. World J Oncol 2020;11:55-64. [PMID: 32284773 DOI: 10.14740/wjon1254] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 17.5] [Reference Citation Analysis]
139 Brancato V, Garbino N, Mannelli L, Aiello M, Salvatore M, Franzese M, Cavaliere C. Impact of radiogenomics in esophageal cancer on clinical outcomes: A pilot study. World J Gastroenterol 2021; 27(36): 6110-6127 [PMID: 34629823 DOI: 10.3748/wjg.v27.i36.6110] [Reference Citation Analysis]
140 Zhang Y, Wang H, Wu K, Liu Z. Expression of 4-hydroxynonenal in esophageal squamous cell carcinoma. Oncol Lett 2017;14:35-40. [PMID: 28693132 DOI: 10.3892/ol.2017.6127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
141 Toyota S, Kimura Y, Fujimoto Y, Jogo T, Hu Q, Hokonohara K, Nakanishi R, Hisamatsu Y, Ando K, Oki E, Oda Y, Miyashita Y, Kohashi K, Mori M. A rare case of esophageal adenocarcinoma with urinary bladder metastasis. Int Cancer Conf J 2020;9:231-4. [PMID: 32904040 DOI: 10.1007/s13691-020-00434-2] [Reference Citation Analysis]
142 Bonde A, Daly S, Kirsten J, Kondapaneni S, Mellnick V, Menias CO, Katabathina VS. Human Gut Microbiota-associated Gastrointestinal Malignancies: A Comprehensive Review. Radiographics 2021;41:1103-22. [PMID: 33989072 DOI: 10.1148/rg.2021200168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
143 Hughes RE, Elliott RJR, Munro AF, Makda A, O'Neill JR, Hupp T, Carragher NO. High-Content Phenotypic Profiling in Esophageal Adenocarcinoma Identifies Selectively Active Pharmacological Classes of Drugs for Repurposing and Chemical Starting Points for Novel Drug Discovery. SLAS Discov 2020;25:770-82. [PMID: 32441181 DOI: 10.1177/2472555220917115] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
144 Gerayllo S, Morowatisharifabad MA, Jouybari L, Amirbeigy MK, Fallahzadeh H. Prevention behaviours of oesophageal cancer: Protocol for a mixed-method study. J Adv Nurs 2019;75:3768-73. [PMID: 31441532 DOI: 10.1111/jan.14178] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
145 Kamarajah SK, Newton N, Navidi M, Wahed S, Immanuel A, Hayes N, Griffin SM, Phillips AW. Long-term outcomes of clinical and pathological-staged T3 N3 esophageal cancer. Dis Esophagus 2020;33:doz109. [PMID: 31950184 DOI: 10.1093/dote/doz109] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
146 Fan Z, Chang Y, Cui C, Sun L, Wang DH, Pan Z, Zhang M. Near infrared fluorescent peptide nanoparticles for enhancing esophageal cancer therapeutic efficacy. Nat Commun 2018;9:2605. [PMID: 29973582 DOI: 10.1038/s41467-018-04763-y] [Cited by in Crossref: 65] [Cited by in F6Publishing: 55] [Article Influence: 16.3] [Reference Citation Analysis]
147 Flores Castro JA, Rasha A, Pandu A, Mushiyev S. Cardiac Tamponade as the Initial Presentation of Metastatic Esophageal Adenocarcinoma. Cureus 2021;13:e16863. [PMID: 34513439 DOI: 10.7759/cureus.16863] [Reference Citation Analysis]
148 Sumarpo A, Ito K, Saiki Y, Ishizawa K, Wang R, Chen N, Sunamura M, Horii A. Genetic and epigenetic aberrations of ABCB1 synergistically boost the acquisition of taxane resistance in esophageal squamous cancer cells. Biochem Biophys Res Commun 2020;526:586-91. [PMID: 32247608 DOI: 10.1016/j.bbrc.2020.03.114] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
149 Hafiz M, Sundaram S, Naqash AR, Speicher J, Sutton A, Walker P, Talaat N. A Rare Case of Squamous Cell Carcinoma of the Esophagus in a Patient With Goltz Syndrome. ACG Case Rep J 2019;6:1-4. [PMID: 31620495 DOI: 10.14309/crj.0000000000000045] [Reference Citation Analysis]
150 Wang L, Huang S, Dang Y, Li M, Bai W, Zhong Z, Zhao H, Li Y, Liu Y, Wu M. Cord blood-derived cytokine-induced killer cellular therapy plus radiation therapy for esophageal cancer: a case report. Medicine (Baltimore) 2014;93:e340. [PMID: 25526496 DOI: 10.1097/MD.0000000000000340] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
151 Alsop BR, Sharma P. Esophageal Cancer. Gastroenterol Clin North Am. 2016;45:399-412. [PMID: 27546839 DOI: 10.1016/j.gtc.2016.04.001] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 13.4] [Reference Citation Analysis]
152 Peng X, Xue H, Lü L, Shi P, Wang J, Wang J. Accumulated promoter methylation as a potential biomarker for esophageal cancer. Oncotarget 2017;8:679-91. [PMID: 27893424 DOI: 10.18632/oncotarget.13510] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
153 Nga WTB, Eloumou SAFB, Engbang JPN, Bell EMD, Mayeh AMM, Atenguena E, Biwole ME, Ayissi GBN, Kenfack G, Noah DN, Luma HN, Sone AM, Ndom P, Ndam ECN. [Prognosis and survival of esophageal cancer in Cameroon: a prognostic study]. Pan Afr Med J 2019;33:73. [PMID: 31448035 DOI: 10.11604/pamj.2019.33.73.16112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
154 He J, Zeng ZC, Shi SM, Yang P. Clinical features, outcomes and treatment-related pneumonitis in elderly patients with esophageal carcinoma. World J Gastroenterol 2014; 20(36): 13185-13190 [PMID: 25278715 DOI: 10.3748/wjg.v20.i36.13185] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
155 Mahmoudian RA, Abbaszadegan MR, Gholamin M. Applying Subtractive Hybridization Technique to Enrich and Amplify Tumor-Specific Transcripts of Esophageal Squamous Cell Carcinoma. Pathol Oncol Res 2017;23:271-9. [DOI: 10.1007/s12253-016-0090-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
156 Deng X, Yin Z, Lu J, Xia Y, Shao L, Hu Q, Zhou Z, Zhang F, Zhou S, Wu Y, Sheng W, Zeng Y. Two-Step Assembling of Near-Infrared “OFF–ON” Fluorescent Nanohybrids for Synchronous Tumor Imaging and MicroRNA Modulation-Based Therapy. ACS Appl Mater Interfaces 2017;9:3294-305. [DOI: 10.1021/acsami.6b11438] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
157 Treitl D, Hurtado M, Ben-david K. Minimally Invasive Esophagectomy: A New Era of Surgical Resection. Journal of Laparoendoscopic & Advanced Surgical Techniques 2016;26:276-80. [DOI: 10.1089/lap.2016.0088] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
158 Matsushita D, Uenosono Y, Arigami T, Yanagita S, Nishizono Y, Hagihara T, Hirata M, Haraguchi N, Arima H, Kijima Y, Kurahara H, Maemura K, Okumura H, Ishigami S, Natsugoe S. Clinical Significance of Circulating Tumor Cells in Peripheral Blood of Patients with Esophageal Squamous Cell Carcinoma. Ann Surg Oncol. 2015;22:3674-3680. [PMID: 25652049 DOI: 10.1245/s10434-015-4392-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
159 Xu Y, Zhao H, Tong Y, Wang W, Huang J, Zhu W. Comparative Analysis of Clinicopathological Characteristics, Survival Features, and Protein Expression Between Basaloid and Squamous Cell Carcinoma of the Esophagus. Int J Gen Med 2021;14:3929-39. [PMID: 34345181 DOI: 10.2147/IJGM.S314054] [Reference Citation Analysis]
160 Bensen R, Brognard J. New Therapeutic Opportunities for the Treatment of Squamous Cell Carcinomas: A Focus on Novel Driver Kinases. Int J Mol Sci 2021;22:2831. [PMID: 33799513 DOI: 10.3390/ijms22062831] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Cai L, Li Y, Sun L, Yang XW, Wang WB, Feng F, Xu GH, Guo M, Lian X, Zhang HW. Better perioperative outcomes in thoracoscopic-esophagectomy with two-lung ventilation in semi-prone position. J Thorac Dis 2017;9:117-22. [PMID: 28203413 DOI: 10.21037/jtd.2017.01.27] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
162 Winiker M, Mantziari S, Figueiredo SG, Demartines N, Allemann P, Schäfer M. Accuracy of preoperative staging for a priori resectable esophageal cancer. Dis Esophagus 2018;31:1-6. [PMID: 29346598 DOI: 10.1093/dote/dox113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
163 Feng JF, Liu JS, Huang Y. Lymphopenia predicts poor prognosis in patients with esophageal squamous cell carcinoma. Medicine (Baltimore). 2014;93:e257. [PMID: 25501097 DOI: 10.1097/md.0000000000000257] [Cited by in Crossref: 40] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
164 Sadrizadeh A, Bagheri R, Soltani E, Anvari K, Toussi MS, Moadikhah S. The Comparison of the Advantages of Neoadjuvant Chemoradiotherapy versus Postoperative Chemoradiotherapy: Outcomes in Esophageal Cancer Patients. J Gastrointest Cancer 2018;49:50-6. [PMID: 28025816 DOI: 10.1007/s12029-016-9899-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
165 Zhang H, Si J, Yue J, Ma S. The mechanisms and reversal strategies of tumor radioresistance in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2021;147:1275-86. [PMID: 33687564 DOI: 10.1007/s00432-020-03493-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
166 Macedo-Silva C, Miranda-Gonçalves V, Lameirinhas A, Lencart J, Pereira A, Lobo J, Guimarães R, Martins AT, Henrique R, Bravo I, Jerónimo C. JmjC-KDMs KDM3A and KDM6B modulate radioresistance under hypoxic conditions in esophageal squamous cell carcinoma. Cell Death Dis 2020;11:1068. [PMID: 33318475 DOI: 10.1038/s41419-020-03279-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
167 Zhao Q, Chen S, Feng JF. A novel inflammation-based prognostic index for patients with esophageal squamous cell carcinoma: neutrophil lymphocyte ratio/albumin ratio. Oncotarget 2017;8:103535-42. [PMID: 29262582 DOI: 10.18632/oncotarget.21989] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
168 Hull R, Mbele M, Makhafola T, Hicks C, Wang SM, Reis RM, Mehrotra R, Mkhize-Kwitshana Z, Hussain S, Kibiki G, Bates DO, Dlamini Z. A multinational review: Oesophageal cancer in low to middle-income countries. Oncol Lett 2020;20:42. [PMID: 32802164 DOI: 10.3892/ol.2020.11902] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
169 Smith MS, Ikonomi E, Bhuta R, Iorio N, Kataria RD, Kaul V, Gross SA; US Collaborative WATS Study Group . Wide-area transepithelial sampling with computer-assisted 3-dimensional analysis (WATS) markedly improves detection of esophageal dysplasia and Barrett's esophagus: analysis from a prospective multicenter community-based study. Dis Esophagus 2019;32:doy099. [PMID: 30541019 DOI: 10.1093/dote/doy099] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
170 Li Q, Ma Q, Xu L, Gao C, Yao L, Wen J, Yang M, Cheng J, Zhou X, Zou J, Zhong X, Guo X. Human Telomerase Reverse Transcriptase as a Therapeutic Target of Dihydroartemisinin for Esophageal Squamous Cancer. Front Pharmacol 2021;12:769787. [PMID: 34744749 DOI: 10.3389/fphar.2021.769787] [Reference Citation Analysis]
171 Liu H, Zhen Q, Fan Y. LncRNA GHET1 promotes esophageal squamous cell carcinoma cells proliferation and invasion via induction of EMT. Int J Biol Markers 2017;32:e403-8. [PMID: 28983895 DOI: 10.5301/ijbm.5000304] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
172 Li J, Chen Y, Chen Z, He A, Xie H, Zhang Q, Cai Z, Liu Y, Huang W. SPRY4-IT1: A novel oncogenic long non-coding RNA in human cancers. Tumour Biol 2017;39:101042831771140. [DOI: 10.1177/1010428317711406] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
173 Asghar MS, Khan NA, Kazmi SJH, Hassan M, Rasheed U, Jawed R, Yaseen R, Naqvi SAA. Clinical, epidemiological, and diagnostic characteristics of esophageal carcinoma in a Pakistani population. Ann Saudi Med 2021;41:91-100. [PMID: 33818145 DOI: 10.5144/0256-4947.2021.91] [Reference Citation Analysis]
174 Ohkura Y, Ueno M, Iizuka T, Haruta S, Tanaka T, Udagawa H. Factors Predicting Effectiveness of Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma. Medicine (Baltimore) 2016;95:e3365. [PMID: 27082598 DOI: 10.1097/MD.0000000000003365] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
175 Zarean E, Mahmoudi M, Azimi T, Amini P. Determining Overall Survival and Risk Factors in Esophageal Cancer Using Censored Quantile Regression. Asian Pac J Cancer Prev 2018;19:3081-6. [PMID: 30485945 DOI: 10.31557/APJCP.2018.19.11.3081] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
176 Chao YK, Peng TL, Chuang WY, Yeh CJ, Li YL, Lu YC, Cheng AJ. Transketolase Serves a Poor Prognosticator in Esophageal Cancer by Promoting Cell Invasion via Epithelial-Mesenchymal Transition. J Cancer 2016;7:1804-11. [PMID: 27698919 DOI: 10.7150/jca.15467] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
177 Li S, Qin X, Chai S, Qu C, Wang X, Zhang H. Modulation of E-cadherin expression promotes migration ability of esophageal cancer cells. Sci Rep 2016;6:21713. [PMID: 26898709 DOI: 10.1038/srep21713] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
178 Wang C, Lu M, Zhou T, Zhao S, Guan S. Intensity-modulated radiotherapy does not decrease the risk of malnutrition in esophageal cancer patients during radiotherapy compared to three-dimensional conformal radiation therapy. J Thorac Dis 2019;11:3721-31. [PMID: 31656644 DOI: 10.21037/jtd.2019.09.33] [Reference Citation Analysis]
179 Guo Y, Liu N, Liu K, Gao M. Capsaicin inhibits the migration and invasion via the AMPK/NF-κB signaling pathway in esophagus sequamous cell carcinoma by decreasing matrix metalloproteinase-9 expression. Biosci Rep 2019;39:BSR20190819. [PMID: 31324733 DOI: 10.1042/BSR20190819] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
180 You BH, Yoon JH, Kang H, Lee EK, Lee SK, Nam JW. HERES, a lncRNA that regulates canonical and noncanonical Wnt signaling pathways via interaction with EZH2. Proc Natl Acad Sci U S A 2019;116:24620-9. [PMID: 31732666 DOI: 10.1073/pnas.1912126116] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
181 Lu C, Yang L, Chen H, Shan Z. Upregulated long non-coding RNA BC032469 enhances carcinogenesis and metastasis of esophageal squamous cell carcinoma through regulating hTERT expression. Tumor Biol 2016;37:16065-75. [DOI: 10.1007/s13277-016-5428-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
182 Peng F, He Q, Cheng C, Pan J. GCNT2 induces epithelial-mesenchymal transition and promotes migration and invasion in esophageal squamous cell carcinoma cells: GCNT2 induces EMT in ESCC cells. Cell Biochem Funct 2019;37:42-51. [DOI: 10.1002/cbf.3371] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
183 Lee F, Sarkaria IS, Luketich JD. Surgeon proficiency and outcomes in esophagectomy: a perspective and comment on an analysis of the Swedish Cancer Registry. J Thorac Dis 2017;9:E279-81. [PMID: 28449520 DOI: 10.21037/jtd.2017.02.92] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
184 Weh KM, Aiyer HS, Howell AB, Kresty LA. Cranberry proanthocyanidins modulate reactive oxygen species in Barrett's and esophageal adenocarcinoma cell lines. J Berry Res 2016;6:125-36. [PMID: 27583064 DOI: 10.3233/JBR-160122] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
185 McGuire AL, Yee J. Commentary: Navigating the perils of neoadjuvant chemoradiation for esophageal surgeons. J Thorac Cardiovasc Surg 2020;159:2108-9. [PMID: 31926732 DOI: 10.1016/j.jtcvs.2019.10.073] [Reference Citation Analysis]
186 Jiang JH, Pi J, Jin H, Yang F, Cai JY. Chinese herb medicine matrine induce apoptosis in human esophageal squamous cancer KYSE-150 cells through increasing reactive oxygen species and inhibiting mitochondrial function. Pathol Res Pract 2018;214:691-9. [PMID: 29567333 DOI: 10.1016/j.prp.2018.03.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
187 Chen X, He LY, Lai S, He Y. Dihydroartemisinin inhibits the migration of esophageal cancer cells by inducing autophagy. Oncol Lett 2020;20:94. [PMID: 32831913 DOI: 10.3892/ol.2020.11955] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
188 Zeng R, Huang JP, Li XF, Xiong WB, Wu G, Jiang ZJ, Song SJ, Li JQ, Zheng YF, Zhang JR. Epb41l3 suppresses esophageal squamous cell carcinoma invasion and inhibits MMP2 and MMP9 expression. Cell Biochem Funct 2016;34:133-41. [PMID: 26916087 DOI: 10.1002/cbf.3170] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
189 Liu J, Wang Y, Chu Y, Xu R, Zhang D, Wang X. Identification of a TLR-Induced Four-lncRNA Signature as a Novel Prognostic Biomarker in Esophageal Carcinoma. Front Cell Dev Biol 2020;8:649. [PMID: 32850794 DOI: 10.3389/fcell.2020.00649] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
190 Xu YJ, Cheng JC, Lee JM, Huang PM, Huang GH, Chen CC. A Walk-and-Eat Intervention Improves Outcomes for Patients With Esophageal Cancer Undergoing Neoadjuvant Chemoradiotherapy. Oncologist 2015;20:1216-22. [PMID: 26341759 DOI: 10.1634/theoncologist.2015-0178] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.7] [Reference Citation Analysis]
191 Chen X, Hu H, Liu J, Yang Y, Liu G, Ying X, Chen Y, Li B, Ye C, Wu D, Duan S. FOXF2 promoter methylation is associated with prognosis in esophageal squamous cell carcinoma. Tumour Biol 2017;39:1010428317692230. [PMID: 28222662 DOI: 10.1177/1010428317692230] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
192 Zhou YX, Liu Q, Wang H, Ding F, Ma YQ. The expression and prognostic value of SOX2, β-catenin and survivin in esophageal squamous cell carcinoma. Future Oncol 2019;15:4181-95. [PMID: 31789057 DOI: 10.2217/fon-2018-0884] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
193 Yajima S, Fukuda T, Oka D, Mishima K, Shibamoto M, Tanaka Y, Kawashima Y. Anomalies of the right vertebral vein increasing the difficulty of lymph-node dissection along the right recurrent laryngeal nerve: a single-institution, retrospective study. Esophagus 2020;17:257-63. [PMID: 32088787 DOI: 10.1007/s10388-020-00723-y] [Reference Citation Analysis]
194 Betancourt Cuellar SL, Palacio DP, Benveniste MF, Carter BW, Hofstetter WL, Marom EM. Positron Emission Tomography/Computed Tomography in Esophageal Carcinoma: Applications and Limitations. Semin Ultrasound CT MR 2017;38:571-83. [PMID: 29179897 DOI: 10.1053/j.sult.2017.07.008] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
195 Maacha S, Hong J, von Lersner A, Zijlstra A, Belkhiri A. AXL Mediates Esophageal Adenocarcinoma Cell Invasion through Regulation of Extracellular Acidification and Lysosome Trafficking. Neoplasia 2018;20:1008-22. [PMID: 30189359 DOI: 10.1016/j.neo.2018.08.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
196 Chen X, Jiang J, Zhao Y, Wang X, Zhang C, Zhuan L, Zhang D, Zheng Y. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p. J Exp Clin Cancer Res 2020;39:133. [PMID: 32653032 DOI: 10.1186/s13046-020-01640-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
197 Yang CL, Zheng XL, Ye K, Ge H, Sun YN, Lu YF, Fan QX. NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway. Int J Biochem Cell Biol 2018;99:43-51. [PMID: 29530788 DOI: 10.1016/j.biocel.2018.03.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
198 Huang Y, Liu JS, Feng JF. The combination of preoperative serum C-reactive protein and carcinoembryonic antigen is a useful prognostic factor in patients with esophageal squamous cell carcinoma: a combined ROC analysis. Onco Targets Ther 2015;8:795-803. [PMID: 25914550 DOI: 10.2147/OTT.S77378] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
199 Peng Y, Zhou Y, Cheng L, Hu D, Zhou X, Wang Z, Xie C, Zhou F. The anti-esophageal cancer cell activity by a novel tyrosine/phosphoinositide kinase inhibitor PP121. Biochem Biophys Res Commun 2015;465:137-44. [PMID: 26235881 DOI: 10.1016/j.bbrc.2015.07.147] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
200 La Francesca S, Aho JM, Barron MR, Blanco EW, Soliman S, Kalenjian L, Hanson AD, Todorova E, Marsh M, Burnette K, DerSimonian H, Odze RD, Wigle DA. Long-term regeneration and remodeling of the pig esophagus after circumferential resection using a retrievable synthetic scaffold carrying autologous cells. Sci Rep. 2018;8:4123. [PMID: 29515136 DOI: 10.1038/s41598-018-22401-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
201 Zheng S, Yang C, Lu M, Liu Q, Liu T, Dai F, Gao X, Sheyhidin I, Lu X. PIK3CA promotes proliferation and motility but is unassociated with lymph node metastasis or prognosis in esophageal squamous cell carcinoma. Hum Pathol 2016;53:121-9. [PMID: 27001433 DOI: 10.1016/j.humpath.2015.11.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
202 Adams O, Janser FA, Dislich B, Berezowska S, Humbert M, Seiler CA, Kroell D, Slotta-Huspenina J, Feith M, Ott K, Tschan MP, Langer R. A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas. PLoS One 2018;13:e0197610. [PMID: 29897944 DOI: 10.1371/journal.pone.0197610] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
203 Zhang G, Liu Y, Dong F, Liu X. Transcription/Expression of KLRB1 Gene as A Prognostic Indicator in Human Esophageal Squamous Cell Carcinoma. Comb Chem High Throughput Screen 2020;23:667-74. [PMID: 32416673 DOI: 10.2174/1386207323666200517114154] [Reference Citation Analysis]
204 Ma J, Wang XB, Li R, Xuan SH, Wang F, Li XH, Zhang ZP, Tan L, Li L. RNAi-mediated TCF-3 gene silencing inhibits proliferation of Eca-109 esophageal cancer cells by inducing apoptosis. Biosci Rep 2017;37:BSR20170799. [PMID: 28864779 DOI: 10.1042/BSR20170799] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
205 Wang WW, Zhao ZH, Wang L, Li P, Chen KS, Zhang JY, Li WC, Jiang GZ, Li XN. MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway. EBioMedicine 2019;46:66-78. [PMID: 31383552 DOI: 10.1016/j.ebiom.2019.07.050] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
206 Fagundes RB, de Carli D, Xaubet RV, Cantarelli JC Jr. Unchanging pattern of prevalence of esophageal cancer, overall and by histological subtype, in the endoscopy service of the main referral hospital in the central region of Rio Grande do Sul State, in Southern Brazil. Dis Esophagus 2016;29:603-6. [PMID: 25967978 DOI: 10.1111/dote.12350] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
207 Khonglah Y, Jitani AK, Gogoi BB, Hage N, Devi LP, Lynrah KG. Concurrent Lesions in Oesophagus: an Approach to Diagnosis with a Case Report. J Gastrointest Cancer 2017;48:201-4. [PMID: 27105636 DOI: 10.1007/s12029-016-9822-8] [Reference Citation Analysis]
208 Deybasso HA, Roba KT, Nega B, Belachew T. Clinico-Pathological Findings and Spatial Distributions of Esophageal Cancer in Arsi Zone, Oromia, Central Ethiopia. Cancer Manag Res 2021;13:2755-62. [PMID: 33790649 DOI: 10.2147/CMAR.S301978] [Reference Citation Analysis]
209 Xiao J, Cheng L, Fang T, Zhang Y, Zhou J, Cheng R, Tang W, Zhong X, Lu Y, Deng L, Cheng Y, Zhu Y, Liu Z, Cui W. Nanoparticle-Embedded Electrospun Fiber-Covered Stent to Assist Intraluminal Photodynamic Treatment of Oesophageal Cancer. Small 2019;15:e1904979. [PMID: 31659867 DOI: 10.1002/smll.201904979] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
210 Liersch-Löhn B, Slavova N, Buhr HJ, Bennani-Baiti IM. Differential protein expression and oncogenic gene network link tyrosine kinase ephrin B4 receptor to aggressive gastric and gastroesophageal junction cancers. Int J Cancer 2016;138:1220-31. [PMID: 26414866 DOI: 10.1002/ijc.29865] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
211 Li J, Zhu SC, Li SG, Zhao Y, Xu JR, Song CY. TKTL1 promotes cell proliferation and metastasis in esophageal squamous cell carcinoma. Biomed Pharmacother 2015;74:71-6. [PMID: 26349965 DOI: 10.1016/j.biopha.2015.07.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
212 Wu Z, Shi Y, Ren S, Ju Y, Hu Y, Wu J. ADAMTS8 Inhibits Progression of Esophageal Squamous Cell Carcinoma. DNA Cell Biol 2020. [PMID: 33054388 DOI: 10.1089/dna.2020.6053] [Reference Citation Analysis]
213 Cools-Lartigue J, Spicer J, Ferri LE. Current status of management of malignant disease: current management of esophageal cancer. J Gastrointest Surg 2015;19:964-72. [PMID: 25650163 DOI: 10.1007/s11605-014-2701-3] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
214 Hagens ERC, Reijntjes MA, Anderegg MCJ, Eshuis WJ, van Berge Henegouwen MI, Gisbertz SS. Risk Factors and Consequences of Anastomotic Leakage After Esophagectomy for Cancer. Ann Thorac Surg 2021;112:255-63. [PMID: 33075324 DOI: 10.1016/j.athoracsur.2020.08.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
215 Renelus BD, Jamorabo DS, Kancharla P, Paul S, Dave N, Briggs WM, Peterson SJ. Racial Disparities with Esophageal Cancer Mortality at a High-Volume University Affiliated Center: An All ACCESS Invitation. J Natl Med Assoc 2020;112:478-83. [PMID: 31072644 DOI: 10.1016/j.jnma.2019.04.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
216 Chen Q, Luo G, Zhang X. MiR-148a modulates HLA-G expression and influences tumor apoptosis in esophageal squamous cell carcinoma. Exp Ther Med 2017;14:4448-52. [PMID: 29067119 DOI: 10.3892/etm.2017.5058] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
217 Zhao L, Ma M, Wu H, Zhang C, Dai S, Dong P, Huo B, Shan B. p-Hydroxylcinnamaldehyde slows the progression of 4NQO-induced oesophageal tumourigenesis via the RhoA-MAPK signaling pathway. Mol Carcinog 2018;57:1319-31. [PMID: 29873419 DOI: 10.1002/mc.22847] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
218 Khadirnaikar S, Narayanan SP, Shukla SK. Decoding the LncRNA transcriptome of esophageal cancer: identification of clinically relevant LncRNAs. Biomark Med 2018;12:1083-93. [PMID: 30191740 DOI: 10.2217/bmm-2018-0032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
219 Zhang G, Zhao J, Jiang M, Zhang L. ING5 inhibits cell proliferation and invasion in esophageal squamous cell carcinoma through regulation of the Akt/NF-κB/MMP-9 signaling pathway. Biochemical and Biophysical Research Communications 2018;496:387-93. [DOI: 10.1016/j.bbrc.2018.01.045] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
220 Chianello Nicolau M, Pinto LFR, Nicolau-Neto P, de Pinho PRA, Rossini A, de Almeida Simão T, Soares Lima SC. Nicotinic cholinergic receptors in esophagus: Early alteration during carcinogenesis and prognostic value. World J Gastroenterol 2016; 22(31): 7146-7156 [PMID: 27610024 DOI: 10.3748/wjg.v22.i31.7146] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
221 Jin Y, Meng Q, Zhang B, Xie C, Chen X, Tian B, Wang J, Shih TC, Zhang Y, Cao J, Yang Y, Chen S, Guan X, Chen X, Hong A. Cancer-associated fibroblasts-derived exosomal miR-3656 promotes the development and progression of esophageal squamous cell carcinoma via the ACAP2/PI3K-AKT signaling pathway. Int J Biol Sci 2021;17:3689-701. [PMID: 34671193 DOI: 10.7150/ijbs.62571] [Reference Citation Analysis]
222 Wen Y, Zhao Z, Miao J, Yang Q, Gui Y, Sun M, Tian H, Jia Q, Liao D, Yang C, Du X. S-1 versus S-1 plus cisplatin concurrent intensity modulated radiation therapy in the treatment of esophageal squamous cell carcinoma: Study protocol for a randomized controlled phase II trial. Medicine (Baltimore) 2017;96:e8998. [PMID: 29245275 DOI: 10.1097/MD.0000000000008998] [Reference Citation Analysis]
223 Zarei M, Jazi MS, Tajaldini M, Khosravi A, Asadi J. Selective Inhibition of Esophageal Cancer Stem-like Cells with Salinomycin. Anticancer Agents Med Chem 2020;20:783-9. [PMID: 32156244 DOI: 10.2174/1871520620666200310093125] [Reference Citation Analysis]
224 Farrow NE, Raman V, Jawitz OK, Voigt SL, Tong BC, Harpole DH Jr, D'Amico TA. Impact of Age on Surgical Outcomes for Locally Advanced Esophageal Cancer. Ann Thorac Surg 2021;111:996-1003. [PMID: 32853569 DOI: 10.1016/j.athoracsur.2020.06.055] [Reference Citation Analysis]
225 Wang X, Pei X, Li X, Gao M, Cheng H, Zhong H, Cao Q. Predictive Value of Anastomotic Blood Supply for Anastomotic Stricture After Esophagectomy in Esophageal Cancer. Dig Dis Sci 2019;64:3307-13. [PMID: 30632053 DOI: 10.1007/s10620-018-5451-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
226 Vingeliene S, Chan DSM, Vieira AR, Polemiti E, Stevens C, Abar L, Navarro Rosenblatt D, Greenwood DC, Norat T. An update of the WCRF/AICR systematic literature review and meta-analysis on dietary and anthropometric factors and esophageal cancer risk. Ann Oncol. 2017;28:2409-2419. [PMID: 28666313 DOI: 10.1093/annonc/mdx338] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
227 Feng JF, Wang L, Yang X, Chen S. Gustave Roussy Immune Score (GRIm-Score) is a prognostic marker in patients with resectable esophageal squamous cell carcinoma. J Cancer 2020;11:1334-40. [PMID: 32047540 DOI: 10.7150/jca.37898] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
228 Zhu Y, Li M, Kong L, Yu J. Postoperative radiation in esophageal squamous cell carcinoma and target volume delineation. Onco Targets Ther 2016;9:4187-96. [PMID: 27471393 DOI: 10.2147/OTT.S104221] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
229 Wang C, Guan S, Liu F, Chen X, Han L, Wang D, Nesa EU, Wang X, Bao C, Wang N. Prognostic and diagnostic potential of miR-146a in oesophageal squamous cell carcinoma. Br J Cancer. 2016;114:290-297. [PMID: 26794279 DOI: 10.1038/bjc.2015.463] [Cited by in Crossref: 26] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
230 Kalikawe R, Baba Y, Nomoto D, Okadome K, Miyake K, Eto K, Hiyoshi Y, Nagai Y, Iwatsuki M, Ishimoto T, Iwagami S, Miyamoto Y, Yoshida N, Watanabe M, Baba H. Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancer. Cancer Sci 2019;110:3727-37. [PMID: 31599475 DOI: 10.1111/cas.14214] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
231 Mantziari S, Allemann P, Winiker M, Sempoux C, Demartines N, Schäfer M. Sterilization of tumor-positive lymph nodes of esophageal cancer by neo-adjuvant treatment is associated with worse survival compared to tumor-negative lymph nodes treated with surgery first. J Surg Oncol 2017;116:524-32. [PMID: 28542983 DOI: 10.1002/jso.24689] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
232 Lin D, Liu G, Jiang D, Yu Y, Wang H, Shi H, Tan L. The role of primary tumor SUVmax in the diagnosis of invasion depth: a step toward clinical T2N0 esophageal cancer. Ann Transl Med 2021;9:112. [PMID: 33569414 DOI: 10.21037/atm-20-4430] [Reference Citation Analysis]
233 Tian X, Sun B, Chen C, Gao C, Zhang J, Lu X, Wang L, Li X, Xing Y, Liu R, Han X, Qi Z, Zhang X, He C, Han D, Yang YG, Kan Q. Circulating tumor DNA 5-hydroxymethylcytosine as a novel diagnostic biomarker for esophageal cancer. Cell Res 2018;28:597-600. [PMID: 29467383 DOI: 10.1038/s41422-018-0014-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
234 Wang F, Zhang C, Cheng H, Liu C, Lu Z, Zheng S, Wang S, Sun N, He J. TGF-β-induced PLEK2 promotes metastasis and chemoresistance in oesophageal squamous cell carcinoma by regulating LCN2. Cell Death Dis 2021;12:901. [PMID: 34601488 DOI: 10.1038/s41419-021-04155-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
235 Xu DQ, Tan XY, Zhang BW, Wu T, Liu P, Sun SJ, Cao YG. 3-Bromopyruvate inhibits cell proliferation and induces apoptosis in CD133+ population in human glioma. Tumour Biol 2016;37:3543-8. [PMID: 26453119 DOI: 10.1007/s13277-015-3884-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
236 Feng Z, Qu J, Liu X, Liang J, Li Y, Jiang J, Zhang H, Tian H. Integrated bioinformatics analysis of differentially expressed genes and immune cell infiltration characteristics in Esophageal Squamous cell carcinoma. Sci Rep 2021;11:16696. [PMID: 34404882 DOI: 10.1038/s41598-021-96274-y] [Reference Citation Analysis]
237 Zhang H, Wang L, Hou Z, Ma H, Mamtimin B, Hasim A, Sheyhidin I. Metabolomic profiling reveals potential biomarkers in esophageal cancer progression using liquid chromatography-mass spectrometry platform. Biochemical and Biophysical Research Communications 2017;491:119-25. [DOI: 10.1016/j.bbrc.2017.07.060] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
238 Deng X, Luo M. Expression of miR-944 in esophageal squamous cell carcinoma and its role in cell proliferation and invasion in human esophageal carcinoma cell line Eca109. Shijie Huaren Xiaohua Zazhi 2017; 25(8): 684-690 [DOI: 10.11569/wcjd.v25.i8.684] [Reference Citation Analysis]
239 Zaidi AH, Kelly RJ, Gorbunova A, Omstead AN, Salvitti MS, Zheng P, Kosovec JE, Lee S, Ayazi S, Babar L, Finley GG, Goel A, Jobe BA. Intratumoral immunotherapy with STING agonist, ADU-S100, induces CD8+ T-cell mediated anti-tumor immunity in an esophageal adenocarcinoma model. Oncotarget 2021;12:292-303. [PMID: 33659041 DOI: 10.18632/oncotarget.27886] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
240 Xu ML, Liu TC, Dong FX, Meng LX, Ling AX, Liu S. Exosomal lncRNA LINC01711 facilitates metastasis of esophageal squamous cell carcinoma via the miR-326/FSCN1 axis. Aging (Albany NY) 2021;13:19776-88. [PMID: 34370713 DOI: 10.18632/aging.203389] [Reference Citation Analysis]
241 Wang C, Li Q, Liu F, Chen X, Nesa EU, Guan S, Liu B, Han L, Tan B, Wang D, Chen P, Liu X, Zhang H, Sun Y, Cheng Y. Serum miR-1297: a promising diagnostic biomarker in esophageal squamous cell carcinoma. Biomarkers 2016;21:517-22. [PMID: 27152453 DOI: 10.3109/1354750X.2016.1160291] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
242 Wang HC, Nguyen NV, Lin RY, Jen CP. Characterizing Esophageal Cancerous Cells at Different Stages Using the Dielectrophoretic Impedance Measurement Method in a Microchip. Sensors (Basel) 2017;17:E1053. [PMID: 28481265 DOI: 10.3390/s17051053] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
243 Stock C. How Dysregulated Ion Channels and Transporters Take a Hand in Esophageal, Liver, and Colorectal Cancer. Rev Physiol Biochem Pharmacol 2020. [PMID: 32875386 DOI: 10.1007/112_2020_41] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
244 Zhai S, Liu C, Zhang L, Zhu J, Guo J, Zhang J, Chen Z, Zhou W, Chang T, Xu S, Qi Y, Zhuang T, Yu N, Wang W, Wang H, Yu S, Li X. PLCE1 Promotes Esophageal Cancer Cell Progression by Maintaining the Transcriptional Activity of Snail. Neoplasia 2017;19:154-64. [PMID: 28147304 DOI: 10.1016/j.neo.2016.12.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
245 Chen X, Hu Y, Zhang Z, Wang B, Zhang L, Shi F, Chen X, Jiang X. A graph-based approach to automated EUS image layer segmentation and abnormal region detection. Neurocomputing 2019;336:79-91. [DOI: 10.1016/j.neucom.2018.03.083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
246 Chen C, Peng H, Huang X, Zhao M, Li Z, Yin N, Wang X, Yu F, Yin B, Yuan Y, Lu Q. Genome-wide profiling of DNA methylation and gene expression in esophageal squamous cell carcinoma. Oncotarget 2016;7:4507-21. [PMID: 26683359 DOI: 10.18632/oncotarget.6607] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
247 Choi J, Chung H, Lee A, Kim JL, Cho SJ, Kim SG. Role of Endoscopic Ultrasound in Selecting Superficial Esophageal Cancers for Endoscopic Resection. Ann Thorac Surg 2021;111:1689-95. [PMID: 32980323 DOI: 10.1016/j.athoracsur.2020.07.029] [Reference Citation Analysis]
248 Xu QR, Tang J, Liao HY, Yu BT, He XY, Zheng YZ, Liu S. Long non-coding RNA MEG3 mediates the miR-149-3p/FOXP3 axis by reducing p53 ubiquitination to exert a suppressive effect on regulatory T cell differentiation and immune escape in esophageal cancer. J Transl Med 2021;19:264. [PMID: 34140005 DOI: 10.1186/s12967-021-02907-1] [Reference Citation Analysis]
249 Lütken CD, Fiehn AK, Federspiel B, Achiam MP. Impact of isolated tumor cells in regional lymph nodes in adeno-and squamous cell carcinoma of the esophagus and the esophagogastric junction-A systematic review. Pathol Res Pract 2019;215:849-54. [PMID: 30723054 DOI: 10.1016/j.prp.2019.01.040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
250 Abbasi BA, Iqbal J, Ahmad R, Bibi S, Mahmood T, Kanwal S, Bashir S, Gul F, Hameed S. Potential phytochemicals in the prevention and treatment of esophagus cancer: A green therapeutic approach. Pharmacological Reports 2019;71:644-52. [DOI: 10.1016/j.pharep.2019.03.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 5.7] [Reference Citation Analysis]
251 Bhat AA, Nisar S, Maacha S, Carneiro-Lobo TC, Akhtar S, Siveen KS, Wani NA, Rizwan A, Bagga P, Singh M, Reddy R, Uddin S, Grivel JC, Chand G, Frenneaux MP, Siddiqi MA, Bedognetti D, El-Rifai W, Macha MA, Haris M. Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy. Mol Cancer 2021;20:2. [PMID: 33390169 DOI: 10.1186/s12943-020-01294-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
252 Baş Y, Aker FV, Gönültaş A, Akdeniz R, Turgal E, Çıkrıkçıoğlu MA. Effect of high-risk human papillomavirus in esophageal squamous cell carcinoma in Somalian and Turkish cases. Pathog Dis 2019;77:ftz047. [PMID: 31504479 DOI: 10.1093/femspd/ftz047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
253 Kang M, Li Y, Zhu S, Zhang S, Guo S, Li P. MicroRNA-193b acts as a tumor suppressor gene in human esophageal squamous cell carcinoma via target regulation of KRAS. Oncol Lett 2019;17:3965-73. [PMID: 30881513 DOI: 10.3892/ol.2019.10039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
254 Li N, Lu Y, Li D, Zheng X, Lian J, Li S, Cui H, Zhang L, Sang L, Wang Y, Yu JJ, Lu T. All-trans retinoic acid suppresses the angiopoietin-Tie2 pathway and inhibits angiogenesis and metastasis in esophageal squamous cell carcinoma. PLoS One 2017;12:e0174555. [PMID: 28369068 DOI: 10.1371/journal.pone.0174555] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
255 Eskes AM, van Ingen CHNM, Horst MEE, Schreuder AM, Chaboyer W, Nieveen van Dijkum EJM. The experiences of family caregivers who participated in a family involvement program after cancer surgery: A qualitative study. Eur J Oncol Nurs 2020;49:101835. [PMID: 33120217 DOI: 10.1016/j.ejon.2020.101835] [Reference Citation Analysis]
256 Tseng KW, Hsiao YP, Jen CP, Chang TS, Wang HC. Cu2O/PEDOT:PSS/ZnO Nanocomposite Material Biosensor for Esophageal Cancer Detection. Sensors (Basel) 2020;20:E2455. [PMID: 32357418 DOI: 10.3390/s20092455] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
257 Findlay M, Purvis M, Venman R, Luong R, Carey S. Nutritional management of patients with oesophageal cancer throughout the treatment trajectory: benchmarking against best practice. Support Care Cancer 2020;28:5963-71. [PMID: 32281035 DOI: 10.1007/s00520-020-05416-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
258 Zaparte A, Cappellari AR, Brandão CA, de Souza JB, Borges TJ, Kist LW, Bogo MR, Zerbini LF, Ribeiro Pinto LF, Glaser T, Gonçalves MCB, Naaldijk Y, Ulrich H, Morrone FB. P2Y2 receptor activation promotes esophageal cancer cells proliferation via ERK1/2 pathway. Eur J Pharmacol 2021;891:173687. [PMID: 33130276 DOI: 10.1016/j.ejphar.2020.173687] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
259 Song G, Liu K, Zhu X, Yang X, Shen Y, Wang W, Shi G, Li Q, Duan Y, Zhao Y, Feng G. The low IGFBP-3 level is associated with esophageal cancer patients: a meta-analysis. World J Surg Oncol 2016;14:307. [PMID: 27978831 DOI: 10.1186/s12957-016-1055-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
260 Wang A, Zhu C, Fu L, Wan X, Yang X, Zhang H, Miao R, He L, Sang X, Zhao H. Citrus Fruit Intake Substantially Reduces the Risk of Esophageal Cancer: A Meta-Analysis of Epidemiologic Studies. Medicine (Baltimore) 2015;94:e1390. [PMID: 26426606 DOI: 10.1097/MD.0000000000001390] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
261 Wang L, Jin JQ, Zhou Y, Tian Z, Jablons DM, He B. Gli is activated and promotes epithelial-mesenchymal transition in human esophageal adenocarcinoma. Oncotarget 2018;9:853-65. [PMID: 29416661 DOI: 10.18632/oncotarget.22856] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
262 Xu S, Zhou Y, Biekemitoufu H, Wang H, Li C, Zhang W, Ma Y. Expression of Twist, Slug and Snail in esophageal squamous cell carcinoma and their prognostic significance. Oncol Lett 2021;21:184. [PMID: 33574923 DOI: 10.3892/ol.2021.12445] [Reference Citation Analysis]
263 Wang C, Li Q, Liu F, Chen X, Liu B, Nesa EU, Guan S, Han L, Tan B, Wang N, Wang X, Song Q, Jia Y, Wang J, Lu M, Cheng Y. Notch2 as a promising prognostic biomarker for oesophageal squamous cell carcinoma. Sci Rep 2016;6:25722. [PMID: 27158037 DOI: 10.1038/srep25722] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
264 Tétreault MP. Esophageal Cancer: Insights From Mouse Models. Cancer Growth Metastasis 2015;8:37-46. [PMID: 26380556 DOI: 10.4137/CGM.S21218] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
265 Khan M, Muzaffar A, Syed AA, Khatak S, Khan AR, Ashraf MI. Changes in oncological outcomes: comparison of the conventional and minimally invasive esophagectomy, a single institution experience. Updates Surg 2016;68:343-9. [PMID: 27629484 DOI: 10.1007/s13304-016-0390-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
266 Du Y, Yan D, Yuan Y, Xu J, Wang S, Yang Z, Cheng W, Tian X, Kan Q. CDK11p110 plays a critical role in the tumorigenicity of esophageal squamous cell carcinoma cells and is a potential drug target. Cell Cycle 2019;18:452-66. [PMID: 30722725 DOI: 10.1080/15384101.2019.1577665] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
267 Haider S, Ahmad H, Shah S, Neelma F, Ullah W. Robust Anti-tumor Response in a Patient with Metastatic Gastroesophageal Junction Adenocarcinoma on Long-term Maintenance Chemotherapy With Trastuzumab Alone: An Unusual Occurrence. Cureus 2020;12:e11472. [PMID: 33329968 DOI: 10.7759/cureus.11472] [Reference Citation Analysis]
268 Song Y, Tao G, Guo Q, Yang X, Zhu H, Wang W, Sun X. Survival benefit of surgery with radiotherapy vs surgery alone to patients with T2-3N0M0 stage esophageal adenocarcinoma. Oncotarget 2016;7:21347-52. [PMID: 26870996 DOI: 10.18632/oncotarget.7256] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
269 Dlamini Z, Hull R, Mbatha SZ, Alaouna M, Qiao YL, Yu H, Chatziioannou A. Prognostic Alternative Splicing Signatures in Esophageal Carcinoma. Cancer Manag Res 2021;13:4509-27. [PMID: 34113176 DOI: 10.2147/CMAR.S305464] [Reference Citation Analysis]
270 Wang L, Cao N, Wang S, Man H, Li P, Shan B. Roles of coinhibitory molecules B7-H3 and B7-H4 in esophageal squamous cell carcinoma. Tumor Biol 2016;37:2961-71. [DOI: 10.1007/s13277-015-4132-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
271 Ma W, Wang S, Zhang T, Zhang EY, Zhou L, Hu C, Yu JJ, Xu G. Activation of choline kinase drives aberrant choline metabolism in esophageal squamous cell carcinomas. J Pharm Biomed Anal 2018;155:148-56. [PMID: 29631075 DOI: 10.1016/j.jpba.2018.03.062] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
272 Cameniţă D, Demetrian AD, Pleşea RM, Tănasie-Vasile MI, Strâmbu VDE, Grigorean VT, Ioniţă E, Pleşea IE, Marincaş AM. Clinical-morphological profiles of esophageal carcinoma's main types. Rom J Morphol Embryol 2020;61:407-22. [PMID: 33544792 DOI: 10.47162/RJME.61.2.10] [Reference Citation Analysis]
273 Baik D, Sheng J, Schlaffer K, Friedenberg FK, Smith MS, Ehrlich AC. Abdominal diameter index is a stronger predictor of prevalent Barrett's esophagus than BMI or waist-to-hip ratio. Dis Esophagus 2017;30:1-6. [PMID: 28859359 DOI: 10.1093/dote/dox056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
274 Li J, Yang X, Zhou X. PIM1 gene silencing inhibits proliferation and promotes apoptosis of human esophageal cancer cell line Eca-109. CBM 2017;18:149-54. [DOI: 10.3233/cbm-160038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
275 Li J, Xie Y, Wang X, Li F, Li S, Li M, Peng H, Yang L, Liu C, Pang L, Zou H, Zhao J, Qi Y, Cao Y, Hu J. Prognostic impact of tumor-associated macrophage infiltration in esophageal cancer: a meta-analysis. Future Oncol. 2019;15:2303-2317. [PMID: 31237146 DOI: 10.2217/fon-2018-0669] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
276 Soletti RC, Biasoli D, Rodrigues NALV, Delou JMA, Maciel R, Chagas VLA, Martins RAP, Rehen SK, Borges HL. Inhibition of pRB Pathway Differentially Modulates Apoptosis in Esophageal Cancer Cells. Transl Oncol 2017;10:726-33. [PMID: 28734226 DOI: 10.1016/j.tranon.2017.06.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
277 Linder G, Korsavidou-Hult N, Bjerner T, Ahlström H, Hedberg J. 18F-FDG-PET/MRI in preoperative staging of oesophageal and gastroesophageal junctional cancer. Clin Radiol 2019;74:718-25. [PMID: 31221468 DOI: 10.1016/j.crad.2019.05.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
278 Favareto SL, Sousa CF, Pinto PJ, Ramos H, Chen MJ, Castro DG, Silva ML, Gondim G, Pellizzon ACA, Fogaroli RC. Clinical Prognostic Factors for Patients With Esophageal Cancer Treated With Definitive Chemoradiotherapy. Cureus 2021;13:e18894. [PMID: 34820218 DOI: 10.7759/cureus.18894] [Reference Citation Analysis]
279 Mi X, Xu R, Hong S, Xu T, Zhang W, Liu M. M2 Macrophage-Derived Exosomal lncRNA AFAP1-AS1 and MicroRNA-26a Affect Cell Migration and Metastasis in Esophageal Cancer. Mol Ther Nucleic Acids 2020;22:779-90. [PMID: 33230475 DOI: 10.1016/j.omtn.2020.09.035] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
280 Jeong HJ, Nam H, Jang J, Lee SJ. 3D Bioprinting Strategies for the Regeneration of Functional Tubular Tissues and Organs. Bioengineering (Basel) 2020;7:E32. [PMID: 32244491 DOI: 10.3390/bioengineering7020032] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
281 Mao N, Nie S, Hong B, Li C, Shen X, Xiong T. Association between alcohol dehydrogenase-2 gene polymorphism and esophageal cancer risk: a meta-analysis. World J Surg Oncol 2016;14:191. [PMID: 27450204 DOI: 10.1186/s12957-016-0937-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
282 Chen GP, Huang Y, Yang X, Feng JF. A Nomogram to Predict Prognostic Value of Red Cell Distribution Width in Patients with Esophageal Cancer. Mediators Inflamm. 2015;2015:854670. [PMID: 26578822 DOI: 10.1155/2015/854670] [Cited by in Crossref: 18] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
283 Strizova Z, Snajdauf M, Stakheev D, Taborska P, Vachtenheim J Jr, Biskup J, Lischke R, Bartunkova J, Smrz D. The paratumoral immune cell signature reveals the potential for the implementation of immunotherapy in esophageal carcinoma patients. J Cancer Res Clin Oncol 2020;146:1979-92. [PMID: 32447483 DOI: 10.1007/s00432-020-03258-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
284 Adams O, Dislich B, Berezowska S, Schläfli AM, Seiler CA, Kröll D, Tschan MP, Langer R. Prognostic relevance of autophagy markers LC3B and p62 in esophageal adenocarcinomas. Oncotarget 2016;7:39241-55. [PMID: 27250034 DOI: 10.18632/oncotarget.9649] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
285 Huang GW, Xue YJ, Wu ZY, Xu XE, Wu JY, Cao HH, Zhu Y, He JZ, Li CQ, Li EM, Xu LY. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma. BMC Cancer 2018;18:147. [PMID: 29409459 DOI: 10.1186/s12885-018-4058-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
286 Xue L, Nan J, Dong L, Zhang C, Li H, Na R, He H, Wang Y. Upregulated miR-483-5p expression as a prognostic biomarker for esophageal squamous cell carcinoma. Cancer Biomark 2017;19:193-7. [PMID: 28211800 DOI: 10.3233/CBM-160506] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
287 Wang D, Nagle PW, Wang HH, Smit JK, Faber H, Baanstra M, Karrenbeld A, Chiu RK, Plukker JTM, Coppes RP. Hedgehog Pathway as a Potential Intervention Target in Esophageal Cancer. Cancers (Basel) 2019;11:E821. [PMID: 31200527 DOI: 10.3390/cancers11060821] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
288 Naik KB, Liu Y, Goodman M, Gillespie TW, Pickens A, Force SD, Steuer CE, Owonikoko TK, Ramalingam SS, Higgins K, Beitler JJ, Shin DM, Willingham FF, El-Rayes B, Landry JC, Fernandez FG, Saba NF. Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base. Cancer 2017;123:3476-85. [PMID: 28464264 DOI: 10.1002/cncr.30763] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
289 Ding X, Qi C, Min J, Xu Z, Huang K, Tang H. Long non-coding RNA HEIH suppresses the expression of TP53 through enhancer of zeste homolog 2 in oesophageal squamous cell carcinoma. J Cell Mol Med 2020;24:10551-9. [PMID: 32729661 DOI: 10.1111/jcmm.15673] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
290 Chen MF, Chen PT, Kuan FC, Chen WC. The Predictive Value of Pretreatment Neutrophil-To-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2019;26:190-9. [PMID: 30362062 DOI: 10.1245/s10434-018-6944-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
291 Sardana RK, Chhikara N, Tanwar B, Panghal A. Dietary impact on esophageal cancer in humans: a review. Food Funct 2018;9:1967-77. [DOI: 10.1039/c7fo01908d] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 7.3] [Reference Citation Analysis]
292 Zhang J, Zhang D, Sun L. Knockdown of Ubiquitin-Specific Protease 14 (USP14) Inhibits the Proliferation and Tumorigenesis in Esophageal Squamous Cell Carcinoma Cells. Oncol Res 2017;25:249-57. [PMID: 27629392 DOI: 10.3727/096504016X693164] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
293 Wong JVS, Fatehi Hassanabad A. Targeting the Mevalonate Pathway for Treating Esophageal Cancer. J Gastrointest Cancer 2021;52:819-21. [PMID: 33931828 DOI: 10.1007/s12029-021-00644-8] [Reference Citation Analysis]
294 Yu S, Yin JJ, Miao JX, Li SG, Huang CZ, Huang N, Fan TL, Li XN, Wang YH, Han SN, Zhang LR. Activation of NLRP3 inflammasome promotes the proliferation and migration of esophageal squamous cell carcinoma. Oncol Rep 2020;43:1113-24. [PMID: 32323780 DOI: 10.3892/or.2020.7493] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
295 Vashisht S, Mishra H, Mishra PK, Ekielski A, Talegaonkar S. Structure, Genome, Infection Cycle and Clinical Manifestations Associated with Human Papillomavirus. Curr Pharm Biotechnol 2019;20:1260-80. [PMID: 31376818 DOI: 10.2174/1389201020666190802115722] [Reference Citation Analysis]
296 Zhu Y, Fu L, Jing W, Guo D, Chen Y, Kong L, Yu J. The value of magnetic resonance imaging in esophageal carcinoma: Tool or toy? Asia‐Pac J Clin Oncol 2019;15:101-7. [DOI: 10.1111/ajco.13112] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
297 Sun P, Zhang F, Chen C, Ren C, Bi XW, Yang H, An X, Wang FH, Jiang WQ. Prognostic impact of body mass index stratified by smoking status in patients with esophageal squamous cell carcinoma. Onco Targets Ther 2016;9:6389-97. [PMID: 27799787 DOI: 10.2147/OTT.S111843] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
298 Xie Y, Wang D, Gao C, Hu J, Zhang M, Gao W, Shu S, Chai X. Effect of perioperative flurbiprofen axetil on long-term survival of patients with esophageal carcinoma who underwent thoracoscopic esophagectomy: A retrospective study. J Surg Oncol 2021;124:540-50. [PMID: 34143443 DOI: 10.1002/jso.26553] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
299 Wang C, Guan S, Chen X, Liu B, Liu F, Han L, Un Nesa E, Song Q, Bao C, Wang X, Cheng Y. Clinical potential of miR-3651 as a novel prognostic biomarker for esophageal squamous cell cancer. Biochem Biophys Res Commun 2015;465:30-4. [PMID: 26210449 DOI: 10.1016/j.bbrc.2015.07.109] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
300 Macedo-Silva C, Miranda-Gonçalves V, Henrique R, Jerónimo C, Bravo I. The Critical Role of Hypoxic Microenvironment and Epigenetic Deregulation in Esophageal Cancer Radioresistance. Genes (Basel) 2019;10:E927. [PMID: 31739546 DOI: 10.3390/genes10110927] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
301 Liu X, Wang Z, Zhang G, Zhu Q, Zeng H, Wang T, Gao F, Qi Z, Zhang J, Wang R. Overexpression of asparaginyl endopeptidase is significant for esophageal carcinoma metastasis and predicts poor patient prognosis. Oncol Lett 2018;15:1229-35. [PMID: 29399177 DOI: 10.3892/ol.2017.7433] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
302 Cui D, Cheung AL. Roles of microRNAs in tumorigenesis and metastasis of esophageal squamous cell carcinoma. World J Clin Oncol 2021; 12(8): 609-622 [PMID: 34513596 DOI: 10.5306/wjco.v12.i8.609] [Reference Citation Analysis]
303 Cui Z, Liu J, Sun Q, He Z, Wang C, Zhang X, Ma Q, Li D, Jiang H. GPR120 promotes radiation resistance in esophageal cancer via regulating AKT and apoptosis pathway. Anticancer Drugs 2021;32:53-60. [PMID: 32932281 DOI: 10.1097/CAD.0000000000000971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
304 Liu S, Dreher PC, Belkoff L, Cahn DB. Metastatic esophageal cancer presenting as bladder mass, a case report. Urol Case Rep 2022;40:101790. [PMID: 34849343 DOI: 10.1016/j.eucr.2021.101790] [Reference Citation Analysis]
305 Zhao H, Mei K, Yang L, Liu X, Xie L. Green tea consumption and risk for esophageal cancer: A systematic review and dose-response meta-analysis. Nutrition 2021;87-88:111197. [PMID: 33744644 DOI: 10.1016/j.nut.2021.111197] [Reference Citation Analysis]
306 Wang M, Liu B, Li D, Wu Y, Wu X, Jiao S, Xu C, Yu S, Wang S, Yang J, Li Y, Wang Q, Luo S, Tang H. Upregulation of IBSP Expression Predicts Poor Prognosis in Patients With Esophageal Squamous Cell Carcinoma. Front Oncol 2019;9:1117. [PMID: 31709184 DOI: 10.3389/fonc.2019.01117] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
307 Kumar N, Deo S, Bhoriwal S, Sharma A, Pramanik R, Kumar R, Das P, Arora S, Kumar S. Comparison of treatment response assessed by 18F-FDG PET/CT with the histopathological response using tumor regression grading on surgically resected specimen following neoadjuvant chemotherapy in squamous cell carcinoma of esophagus. Nucl Med Commun 2021;42:928-34. [PMID: 33795613 DOI: 10.1097/MNM.0000000000001413] [Reference Citation Analysis]
308 Xie L, Li LY, Zheng D, Xie YM, Xu XE, Tao LH, Liao LD, Xie YH, Cheng YW, Xu LY, Li EM. F806 Suppresses the Invasion and Metastasis of Esophageal Squamous Cell Carcinoma via Downregulating F-Actin Assembly-Related Rho Family Proteins. Biomed Res Int 2018;2018:2049313. [PMID: 30327774 DOI: 10.1155/2018/2049313] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
309 Jia Y, Wang H, Wang Y, Wang T, Wang M, Ma M, Duan Y, Meng X, Liu L. Low expression of Bin1, along with high expression of IDO in tumor tissue and draining lymph nodes, are predictors of poor prognosis for esophageal squamous cell cancer patients. Int J Cancer 2015;137:1095-106. [PMID: 25683635 DOI: 10.1002/ijc.29481] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 8.1] [Reference Citation Analysis]
310 Blais E, Vendrely V, Sargos P, Créhange G, Huguet F, Maingon P, Simon JM, Bourdais R, Ozsahin M, Bourhis J, Clément-Colmou K, Belghith B, Proudhom Briois MA, Gilliot O, Dujols JP, Peyras A, Dupin C, Riet FG, Canova CH, Huertas A, Troussier I. [Chemoradiation for oesophageal cancer: A critical review of the literature]. Cancer Radiother 2019;23:62-72. [PMID: 30639379 DOI: 10.1016/j.canrad.2018.05.003] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
311 Xiao X, Jiang L, Hu H, Huang Y, Yang L, Jiao Y, Wei G. Silencing of UAP1L1 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma. Mol Carcinog 2021;60:179-87. [PMID: 33434300 DOI: 10.1002/mc.23278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
312 Li J, Zhao Z, Du G, Dai T, Zhen X, Cai H, Liao D, Xiang M, Wen Y, Geng L, Yang X, Feng G, Zhang Y, Bai J, Liu L, Du X. Safety and efficacy of pulsed low-dose rate radiotherapy for local recurrent esophageal squamous cell carcinoma after radiotherapy: Study protocol for a prospective multi-center phase II trial. Medicine (Baltimore) 2019;98:e16176. [PMID: 31261551 DOI: 10.1097/MD.0000000000016176] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
313 Sun YH, Lin SW, Chen CH, Liang WY, Hsieh CC. Adenosquamous Carcinoma of the Esophagus and Esophagogastric Junction: Clinical Manifestations and Treatment Outcomes. J Gastrointest Surg 2015;19:1216-22. [PMID: 25967141 DOI: 10.1007/s11605-015-2852-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
314 Yang C, Zheng S, Liu Q, Liu T, Lu M, Dai F, Gao X, Sheyhidin I, Lu X. Metadherin is required for the proliferation, migration, and invasion of esophageal squamous cell carcinoma and its meta-analysis. Translational Research 2015;166:614-626.e2. [DOI: 10.1016/j.trsl.2015.05.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
315 Chen S, Yang X, Feng JF. A novel inflammation-based prognostic score for patients with esophageal squamous cell carcinoma: the c-reactive protein/prognostic nutritional index ratio. Oncotarget 2016;7:62123-32. [PMID: 27557504 DOI: 10.18632/oncotarget.11389] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
316 Wang C, Li S, Liu J, Cheng M, Wang D, Wang Y, Lu B. Silencing of S-phase kinase-associated protein 2 enhances radiosensitivity of esophageal cancer cells through inhibition of PI3K/AKT signaling pathway. Genomics 2020;112:3504-10. [PMID: 32360515 DOI: 10.1016/j.ygeno.2020.04.029] [Reference Citation Analysis]
317 Alaei S, Sadeghi B, Najafi A, Masoudi-Nejad A. LncRNA and mRNA integration network reconstruction reveals novel key regulators in esophageal squamous-cell carcinoma. Genomics 2019;111:76-89. [PMID: 29317304 DOI: 10.1016/j.ygeno.2018.01.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
318 Sundaram GM, Veera Bramhachari P. Molecular interplay of pro-inflammatory transcription factors and non-coding RNAs in esophageal squamous cell carcinoma. Tumour Biol 2017;39:1010428317705760. [PMID: 28618941 DOI: 10.1177/1010428317705760] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
319 Yang J, Shang J, Song Q, Yang Z, Chen J, Yu Y, Shi L. ECCDIA: an interactive web tool for the comprehensive analysis of clinical and survival data of esophageal cancer patients. BMC Cancer 2020;20:985. [PMID: 33046018 DOI: 10.1186/s12885-020-07479-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
320 Wang X, Cheng G, Zhang T, Deng L, Xu K, Xu X, Wang W, Zhou Z, Feng Q, Chen D, Bi N, Wang L. CHST15 promotes the proliferation of TE‑1 cells via multiple pathways in esophageal cancer. Oncol Rep 2020;43:75-86. [PMID: 31746400 DOI: 10.3892/or.2019.7395] [Reference Citation Analysis]
321 Hu D, Lin X, Chen Y, Chang Q, Chen G, Li C, Zhang H, Cui Z, Liang B, Jiang W. Preoperative blood-routine markers and prognosis of esophageal squamous cell carcinoma: The Fujian prospective investigation of cancer (FIESTA) study. Oncotarget. 2017;8:23841-23850. [PMID: 27852044 DOI: 10.18632/oncotarget.13318] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
322 Kurten RC, Rawson R, Shoda T, Duong LD, Adejumobi D, Levy R, Newbury RO, Rothenberg ME, Akuthota P, Wright BL, Dohil R, Jones SM, Aceves SS. Development and Application of a Functional Human Esophageal Mucosa Explant Platform to Eosinophilic Esophagitis. Sci Rep 2019;9:6206. [PMID: 30996235 DOI: 10.1038/s41598-019-41147-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
323 Kar R, Jha SK, Ojha S, Sharma A, Dholpuria S, Raju VSR, Prasher P, Chellappan DK, Gupta G, Kumar Singh S, Paudel KR, Hansbro PM, Kumar Singh S, Ruokolainen J, Kesari KK, Dua K, Jha NK. The FBXW7-NOTCH interactome: A ubiquitin proteasomal system-induced crosstalk modulating oncogenic transformation in human tissues. Cancer Rep (Hoboken) 2021;4:e1369. [PMID: 33822486 DOI: 10.1002/cnr2.1369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
324 Song H, Song J, Lu L, Li S. SNHG8 is upregulated in esophageal squamous cell carcinoma and directly sponges microRNA-411 to increase oncogenicity by upregulating KPNA2. Onco Targets Ther 2019;12:6991-7004. [PMID: 31695414 DOI: 10.2147/OTT.S214881] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
325 Jia Y, Xiao Z, Gongsun X, Xin Z, Shang B, Chen G, Wang Z, Jiang W. CEP55 promotes the proliferation, migration and invasion of esophageal squamous cell carcinoma via the PI3K/Akt pathway. Onco Targets Ther 2018;11:4221-32. [PMID: 30050313 DOI: 10.2147/OTT.S168861] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
326 Bakhos CT, Acevedo E Jr, Petrov RV, Abbas AE. Surveillance Following Treatment of Esophageal Cancer. Surg Clin North Am 2021;101:499-509. [PMID: 34048769 DOI: 10.1016/j.suc.2021.03.011] [Reference Citation Analysis]
327 Mitra S, Ganguli S, Chakrabarti J. Introduction. Cancer and Noncoding RNAs. Elsevier; 2018. pp. 1-23. [DOI: 10.1016/b978-0-12-811022-5.00001-2] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
328 Chen X, Zhu CC, Yin J. Ensemble of decision tree reveals potential miRNA-disease associations. PLoS Comput Biol 2019;15:e1007209. [PMID: 31329575 DOI: 10.1371/journal.pcbi.1007209] [Cited by in Crossref: 58] [Cited by in F6Publishing: 48] [Article Influence: 19.3] [Reference Citation Analysis]
329 Luo J, Chen XQ, Li P. The Role of TGF-β and Its Receptors in Gastrointestinal Cancers. Transl Oncol 2019;12:475-84. [PMID: 30594036 DOI: 10.1016/j.tranon.2018.11.010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 9.0] [Reference Citation Analysis]
330 Melsens E, De Vlieghere E, Descamps B, Vanhove C, De Wever O, Ceelen W, Pattyn P. Improved xenograft efficiency of esophageal adenocarcinoma cell lines through in vivo selection. Oncol Rep 2017;38:71-81. [PMID: 28504813 DOI: 10.3892/or.2017.5640] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
331 Meng J, Zhang C, Zhao T, Shi G, Zhao J, Lin Z. MicroRNA-210 targets FBXO31 to inhibit tumor progression and regulates the Wnt/β-catenin signaling pathway and EMT in esophageal squamous cell carcinoma. Thorac Cancer 2021;12:932-40. [PMID: 33538099 DOI: 10.1111/1759-7714.13860] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
332 Pan G, Pan H, Zhang Y, Shuai H. Effects of lymph node metastasis of thoracic esophageal squamous cell carcinoma on design of radiotherapy target volume. Pak J Med Sci 2019;35:177-82. [PMID: 30881419 DOI: 10.12669/pjms.35.1.431] [Reference Citation Analysis]
333 Souza-Santos PT, Soares Lima SC, Nicolau-Neto P, Boroni M, Meireles Da Costa N, Brewer L, Menezes AN, Furtado C, Moreira MAM, Seuanez HN, de Almeida Simão T, Ribeiro Pinto LF. Mutations, Differential Gene Expression, and Chimeric Transcripts in Esophageal Squamous Cell Carcinoma Show High Heterogeneity. Transl Oncol 2018;11:1283-91. [PMID: 30172240 DOI: 10.1016/j.tranon.2018.08.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
334 Kanaan C, Lorenzo D, Barret M, Audebourg A, Leblanc S, Chaussade S, Prat F, Terris B. Early esophageal squamous cell carcinoma in a western series is not associated with active HPV infection. Virchows Arch 2020;477:697-704. [PMID: 32524184 DOI: 10.1007/s00428-020-02860-2] [Reference Citation Analysis]
335 Kumble LD, Silver E, Oh A, Abrams JA, Sonett JR, Hur C. Treatment of early stage (T1) esophageal adenocarcinoma: Personalizing the best therapy choice. World J Meta-Anal 2019; 7(9): 406-417 [DOI: 10.13105/wjma.v7.i9.406] [Reference Citation Analysis]
336 Weh KM, Howell AB, Kresty LA. Expression, modulation, and clinical correlates of the autophagy protein Beclin-1 in esophageal adenocarcinoma. Mol Carcinog 2016;55:1876-85. [PMID: 27696537 DOI: 10.1002/mc.22432] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
337 Wang H, Zhou Y, Liu Q, Xu J, Ma Y. Prognostic value of SOX2, Cyclin D1, P53, and ki-67 in patients with esophageal squamous cell carcinoma. Onco Targets Ther 2018;11:5171-81. [PMID: 30210237 DOI: 10.2147/OTT.S160066] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
338 Rogers MP, DeSantis AJ, DuCoin CG. Oligometastatic Adenocarcinoma of the Esophagus: Current Understanding, Diagnosis, and Therapeutic Strategies. Cancers (Basel) 2021;13:4352. [PMID: 34503162 DOI: 10.3390/cancers13174352] [Reference Citation Analysis]
339 Kunzmann AT, McMenamin ÚC, Spence AD, Gray RT, Murray LJ, Turkington RC, Coleman HG. Blood biomarkers for early diagnosis of oesophageal cancer: a systematic review. Eur J Gastroenterol Hepatol 2018;30:263-73. [PMID: 29189391 DOI: 10.1097/MEG.0000000000001029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
340 Wang SE, Hodge AM, Dashti SG, Dixon-Suen SC, Mitchell H, Thomas RJ, Williamson EM, Makalic E, Boussioutas A, Haydon AM, Giles GG, Milne RL, Kendall BJ, English DR. Diet and risk of gastro-oesophageal reflux disease in the Melbourne Collaborative Cohort Study. Public Health Nutr 2021;:1-13. [PMID: 33472714 DOI: 10.1017/S1368980021000197] [Reference Citation Analysis]
341 Wen L, Mao W, Xu L, Cai B, Gu L. Sesamin exerts anti-tumor activity in esophageal squamous cell carcinoma via inhibition of TRIM44 and NF-κB signaling. Chem Biol Drug Des 2021. [PMID: 34411455 DOI: 10.1111/cbdd.13937] [Reference Citation Analysis]
342 Klevebro F, Scandavini CM, Kamiya S, Nilsson M, Lundell L, Rouvelas I. Single center consecutive series cohort study of minimally invasive versus open resection for cancer in the esophagus or gastroesophageal junction. Diseases of the Esophagus 2018;31. [DOI: 10.1093/dote/doy027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
343 Yang P, Huang P, Yong L, Chang Y, Wu C, Hua K, Hsieh M, Lee J. Circulating Interleukin-6 is Associated with Prognosis and Genetic Polymorphisms of MIR608 in Patients with Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2018;25:2449-56. [DOI: 10.1245/s10434-018-6532-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
344 Chen MF, Chen PT, Lu MS, Lee CP, Chen WC. Survival benefit of surgery to patients with esophageal squamous cell carcinoma. Sci Rep 2017;7:46139. [PMID: 28383075 DOI: 10.1038/srep46139] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
345 Stephens JA, Fisher JL, Krok-Schoen JL, Baltic RD, Sobotka HL, Paskett ED. Esophageal Adenocarcinoma: Opportunities for Targeted Prevention in Ohio. Clin Med Insights Gastroenterol 2018;11:1179552218791170. [PMID: 30083064 DOI: 10.1177/1179552218791170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
346 Kamarajah SK, Navidi M, Wahed S, Immanuel A, Hayes N, Griffin SM, Phillips AW. Significance of Neoadjuvant Downstaging in Carcinoma of Esophagus and Gastroesophageal Junction. Ann Surg Oncol 2020;27:3182-92. [PMID: 32201923 DOI: 10.1245/s10434-020-08358-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
347 Li Y, Du L, Wang Y, Gu Y, Zhen X, Hu X, Sun X, Dong H. Modeling the Cost-effectiveness of Esophageal Cancer Screening in China. Cost Eff Resour Alloc 2020;18:33. [PMID: 32944005 DOI: 10.1186/s12962-020-00230-y] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
348 Li S, Shen XY, Ouyang T, Qu Y, Luo T, Wang HQ. Synergistic anticancer effect of combined crocetin and cisplatin on KYSE-150 cells via p53/p21 pathway. Cancer Cell Int 2017;17:98. [PMID: 29093644 DOI: 10.1186/s12935-017-0468-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
349 Chen S, Zhou K, Yang L, Ding G, Li H. Racial Differences in Esophageal Squamous Cell Carcinoma: Incidence and Molecular Features. Biomed Res Int 2017;2017:1204082. [PMID: 28393072 DOI: 10.1155/2017/1204082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
350 Lu M, Zheng ST, Liu Q, Liu T, Gao XP, Ilyar∙Sheyhidin, Lu XM. Role of PIK3CA in cell proliferation, migration and apoptosis in human esophageal squamous cell carcinoma cell line Ecal09. Shijie Huaren Xiaohua Zazhi 2014; 22(32): 4893-4900 [DOI: 10.11569/wcjd.v22.i32.4893] [Reference Citation Analysis]
351 Lampis A, Ratti M, Ghidini M, Mirchev MB, Okuducu AF, Valeri N, Hahne JC. Challenges and perspectives for immunotherapy in oesophageal cancer: A look to the future (Review). Int J Mol Med 2021;47:97. [PMID: 33846775 DOI: 10.3892/ijmm.2021.4930] [Reference Citation Analysis]
352 Xu YF, Du XF, Li ZY, Fang ZP, Zhang FB. Lesion human leukocyte antigen-E is associated with favourable prognosis for patients with oesophageal squamous cell carcinoma. J Int Med Res 2021;49:3000605211047278. [PMID: 34617814 DOI: 10.1177/03000605211047278] [Reference Citation Analysis]
353 Mallis P, Chachlaki P, Katsimpoulas M, Stavropoulos-Giokas C, Michalopoulos E. Optimization of Decellularization Procedure in Rat Esophagus for Possible Development of a Tissue Engineered Construct. Bioengineering (Basel) 2018;6:E3. [PMID: 30586900 DOI: 10.3390/bioengineering6010003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
354 Xin Z, Xin G, Shi M, Song L, Wang Q, Jiang B, Liu X. Inhibition of MUC1-C entering nuclear suppresses MYC expression and attenuates malignant growth in esophageal squamous cell carcinoma. Onco Targets Ther 2018;11:4125-36. [PMID: 30050304 DOI: 10.2147/OTT.S168813] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
355 Pan X, Liao M, Ma H, Jiang X, Huang H, Wei M, Li Q. Chemoradiotherapy and Increased Prescription Dose in Esophageal Squamous Cell Cancer: A Retrospective Study. Biomed Res Int 2021;2021:3834040. [PMID: 33628778 DOI: 10.1155/2021/3834040] [Reference Citation Analysis]
356 Zhao S, Jiang Y, Zhao J, Li H, Yin X, Wang Y, Xie Y, Chen X, Lu J, Dong Z, Liu K. Quercetin‐3‐methyl ether inhibits esophageal carcinogenesis by targeting the AKT/mTOR/p70S6K and MAPK pathways. Molecular Carcinogenesis 2018;57:1540-52. [DOI: 10.1002/mc.22876] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
357 Hocazade C, Özdemir N, Yazici O, Bozkaya Y, Yazılıtaş D, Toptaş Ş, Zengin N, Deren T. Concordance of positron emission tomography and computed tomography in patients with locally advanced gastric and esophageal cancer. Ann Nucl Med 2015;29:621-6. [DOI: 10.1007/s12149-015-0985-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
358 Chen X, Li Q, Wang C, Xu W, Han L, Liu Y, Liu B, Guan S, Tan B, Wang J, Wang N, Song Q, Jia Y, Wang J, Zhao L, Cheng Y. Prognostic and diagnostic potential of isocitrate dehydrogenase 1 in esophageal squamous cell carcinoma. Oncotarget 2016;7:86148-60. [PMID: 27863386 DOI: 10.18632/oncotarget.13351] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
359 Ro TH, Mathew MA, Misra S. Value of screening endoscopy in evaluation of esophageal, gastric and colon cancers. World J Gastroenterol 2015; 21(33): 9693-9706 [PMID: 26361416 DOI: 10.3748/wjg.v21.i33.9693] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
360 Ramirez JG, Smit DJ, Viol F, Schrader J, Ghadban T, Pantel K, Izbicki JR, Reeh M. High Serum Levels of Wnt Signaling Antagonist Dickkopf-Related Protein 1 Are Associated with Impaired Overall Survival and Recurrence in Esophageal Cancer Patients. Cancers (Basel) 2021;13:4980. [PMID: 34638464 DOI: 10.3390/cancers13194980] [Reference Citation Analysis]
361 Aurello P, Magistri P, Berardi G, Petrucciani N, Sirimarco D, Antolino L, Nigri G, D'Angelo F, Ramacciato G. Transthoracically or transabdominally: how to approach adenocarcinoma of the distal esophagus and cardia. A meta-analysis. Tumori 2016;102:352-60. [PMID: 27230277 DOI: 10.5301/tj.5000517] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
362 Wang X, Wang X. Long non-coding RNA colon cancer-associated transcript 2 may promote esophageal cancer growth and metastasis by regulating the Wnt signaling pathway. Oncol Lett 2019;18:1745-54. [PMID: 31423241 DOI: 10.3892/ol.2019.10488] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
363 Wei XL, Wang FH, Zhang DS, Qiu MZ, Ren C, Jin Y, Zhou YX, Wang DS, He MM, Bai L, Wang F, Luo HY, Li YH, Xu RH. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio. BMC Cancer 2015;15:350. [PMID: 25934640 DOI: 10.1186/s12885-015-1379-6] [Cited by in Crossref: 85] [Cited by in F6Publishing: 97] [Article Influence: 12.1] [Reference Citation Analysis]
364 Li P, Liu X, Dong ZM, Ling ZQ. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma. Oncotarget 2015;6:38151-65. [PMID: 26510908 DOI: 10.18632/oncotarget.5832] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
365 Yokobori T, Bao P, Fukuchi M, Altan B, Ozawa D, Rokudai S, Bai T, Kumakura Y, Honjo H, Hara K, Sakai M, Sohda M, Miyazaki T, Ide M, Nishiyama M, Oyama T, Kuwano H. Nuclear PROX1 is Associated with Hypoxia-Inducible Factor 1α Expression and Cancer Progression in Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2015;22 Suppl 3:S1566-73. [PMID: 26310281 DOI: 10.1245/s10434-015-4831-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
366 Zhang Y, Zhang L, Wang R, Wang B, Hua P, Li J. LncRNA Erbb4‐IR promotes esophageal squamous cell carcinoma (ESCC) by downregulating miR‐145. J Cell Biochem 2019;120:17566-72. [DOI: 10.1002/jcb.29023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
367 Avgeris M, Panoutsopoulou K, Papadimitriou MA, Scorilas A. Circulating exosomal miRNAs: clinical significance in human cancers. Expert Rev Mol Diagn 2019;19:979-95. [PMID: 31594418 DOI: 10.1080/14737159.2019.1673732] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
368 Vasanthan KS, Srinivasan V, Mathur V, Agarwal P, Negi N, Kumari S. 3D Bioprinting for esophageal tissue regeneration: A review. Journal of Materials Research. [DOI: 10.1557/s43578-021-00409-w] [Reference Citation Analysis]
369 Zhou YX, Zhou KM, Liu Q, Wang H, Wang W, Shi Y, Ma YQ. The effect of Glut1 and c-myc on prognosis in esophageal squamous cell carcinoma of Kazakh and Han patients. Future Oncol 2018;14:1801-15. [PMID: 29629851 DOI: 10.2217/fon-2017-0734] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
370 Takeda FR, Tustumi F, Nigro BC, Sallum RAA, Ribeiro-Junior U, Cecconello I. TRANSHIATAL ESOPHAGECTOMY IS NOT ASSOCIATED WITH POOR QUALITY LYMPHADENECTOMY. Arq Bras Cir Dig 2019;32:e1475. [PMID: 31859928 DOI: 10.1590/0102-672020190001e1475] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
371 Rouphael C, Kamal A, Sanaka MR, Thota PN. Vitamin D in esophageal cancer: Is there a role for chemoprevention? World J Gastrointest Oncol 2018; 10(1): 23-30 [PMID: 29375745 DOI: 10.4251/wjgo.v10.i1.23] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
372 Wang Z, Zhang N, Song R, Fan R, Yang L, Wu L. Activin A expression in esophageal carcinoma and its association with tumor aggressiveness and differentiation. Oncol Lett 2015;10:143-8. [PMID: 26170990 DOI: 10.3892/ol.2015.3248] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]